BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 019477
(340 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 101 bits (252), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 49/108 (45%), Positives = 75/108 (69%), Gaps = 1/108 (0%)
Query: 221 DENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS 280
+E+ E + + +F ++VA+DNFS+ N LG+GGFG VYKG L++G +AVKRL +
Sbjct: 15 EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 74
Query: 281 KQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL 327
Q GE++F+ EV +++ HRNL+RL GFC+ ER+LVY ++ N S+
Sbjct: 75 XQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 122
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 99.4 bits (246), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 48/108 (44%), Positives = 74/108 (68%), Gaps = 1/108 (0%)
Query: 221 DENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS 280
+E+ E + + +F ++VA+DNF + N LG+GGFG VYKG L++G +AVKRL +
Sbjct: 7 EEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEER 66
Query: 281 KQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL 327
Q GE++F+ EV +++ HRNL+RL GFC+ ER+LVY ++ N S+
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 43/118 (36%), Positives = 73/118 (61%), Gaps = 11/118 (9%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSD------ANKLGQGGFGAVYKGMLSNGETIAV 273
E++++E + + F F ++ T+NF + NK+G+GGFG VYKG ++N T+AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAV 59
Query: 274 KRLSK----NSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL 327
K+L+ +++ + +F E+ ++A+ QH NLV LLGF + + LVY ++PN SL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 43/118 (36%), Positives = 73/118 (61%), Gaps = 11/118 (9%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSD------ANKLGQGGFGAVYKGMLSNGETIAV 273
E++++E + + F F ++ T+NF + NK+G+GGFG VYKG ++N T+AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAV 59
Query: 274 KRLSK----NSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL 327
K+L+ +++ + +F E+ ++A+ QH NLV LLGF + + LVY ++PN SL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 44/117 (37%), Positives = 70/117 (59%), Gaps = 7/117 (5%)
Query: 223 NVEETIAKSLQFDFETIRV-------ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKR 275
++ + ++ S FE+ RV AT+NF +G G FG VYKG+L +G +A+KR
Sbjct: 11 SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 276 LSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF 332
+ S QG EF+ E+ L+ +H +LV L+GFC ER E IL+Y+++ N +L ++
Sbjct: 71 RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY 127
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 44/117 (37%), Positives = 70/117 (59%), Gaps = 7/117 (5%)
Query: 223 NVEETIAKSLQFDFETIRV-------ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKR 275
++ + ++ S FE+ RV AT+NF +G G FG VYKG+L +G +A+KR
Sbjct: 11 SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 276 LSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF 332
+ S QG EF+ E+ L+ +H +LV L+GFC ER E IL+Y+++ N +L ++
Sbjct: 71 RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY 127
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 41/104 (39%), Positives = 65/104 (62%), Gaps = 11/104 (10%)
Query: 234 FDFETIRVATDNFSD------ANKLGQGGFGAVYKGMLSNGETIAVKRLSK----NSKQG 283
F F ++ T+NF + NK+G+GGFG VYKG ++N T+AVK+L+ +++
Sbjct: 9 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 284 EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL 327
+ +F E+ ++A+ QH NLV LLGF + + LVY ++PN SL
Sbjct: 68 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 111
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 41/104 (39%), Positives = 62/104 (59%), Gaps = 11/104 (10%)
Query: 234 FDFETIRVATDNFSD------ANKLGQGGFGAVYKGMLSNGETIAVKRLSK----NSKQG 283
F F ++ T+NF + NK G+GGFG VYKG ++N T+AVK+L+ +++
Sbjct: 6 FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 284 EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL 327
+ +F E+ + A+ QH NLV LLGF + + LVY + PN SL
Sbjct: 65 KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSL 108
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 39/120 (32%), Positives = 63/120 (52%), Gaps = 8/120 (6%)
Query: 219 LEDENVEETIAKSLQFDFETIRVATDN-FSDANKLGQGGFGAVYKGM-LSNGETI----A 272
LE E VE + +R+ + LG G FG VYKG+ + GET+ A
Sbjct: 12 LETELVEPLTPSGTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVA 71
Query: 273 VKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+K L++ + + +EF +E L++A + H +LVRLLG CL + LV + +P+ L ++
Sbjct: 72 IKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYV 130
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 33/86 (38%), Positives = 53/86 (61%), Gaps = 7/86 (8%)
Query: 252 LGQGGFGAVYKGM-LSNGETI----AVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRL 305
LG G FG VYKG+ + GET+ A+K L++ + + +EF +E L++A + H +LVRL
Sbjct: 23 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 306 LGFCLERKERILVYEFVPNASLDHFI 331
LG CL + LV + +P+ L ++
Sbjct: 83 LGVCLSPTIQ-LVTQLMPHGCLLEYV 107
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
V N + LG G FG VY+G +S +AVK L + S+Q E++F E L+
Sbjct: 28 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 87
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+++L H+N+VR +G L+ R ++ E + L F+
Sbjct: 88 ISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 125
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
V N + LG G FG VY+G +S +AVK L + S+Q E++F E L+
Sbjct: 42 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 101
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+++L H+N+VR +G L+ R ++ E + L F+
Sbjct: 102 ISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 139
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSK-NSKQGEIEFKNEVLL 293
V N + LG G FG VY+G +S +AVK L + S+Q E++F E L+
Sbjct: 42 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALI 101
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+++ H+N+VR +G L+ R ++ E + L F+
Sbjct: 102 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 139
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
V N + LG G FG VY+G +S +AVK L + S+Q E++F E L+
Sbjct: 28 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 87
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+++ H+N+VR +G L+ R ++ E + L F+
Sbjct: 88 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 125
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
V N + LG G FG VY+G +S +AVK L + S+Q E++F E L+
Sbjct: 28 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 87
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+++ H+N+VR +G L+ R ++ E + L F+
Sbjct: 88 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 125
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
V N + LG G FG VY+G +S +AVK L + S+Q E++F E L+
Sbjct: 42 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 101
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+++ H+N+VR +G L+ R ++ E + L F+
Sbjct: 102 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL 139
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
V N + LG G FG VY+G +S +AVK L + S+Q E++F E L+
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+++ H+N+VR +G L+ R ++ E + L F+
Sbjct: 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL 124
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
V N + LG G FG VY+G +S +AVK L + S+Q E++F E L+
Sbjct: 44 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 103
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+++ H+N+VR +G L+ R ++ E + L F+
Sbjct: 104 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 141
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
V N + LG G FG VY+G +S +AVK L + S+Q E++F E L+
Sbjct: 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 127
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+++ H+N+VR +G L+ R ++ E + L F+
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 165
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
V N + LG G FG VY+G +S +AVK L + S+Q E++F E L+
Sbjct: 19 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 78
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+++ H+N+VR +G L+ R ++ E + L F+
Sbjct: 79 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 116
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
V N + LG G FG VY+G +S +AVK L + S+Q E++F E L+
Sbjct: 45 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 104
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+++ H+N+VR +G L+ R ++ E + L F+
Sbjct: 105 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 142
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
V N + LG G FG VY+G +S +AVK L + S+Q E++F E L+
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+++ H+N+VR +G L+ R ++ E + L F+
Sbjct: 87 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 124
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
V N + LG G FG VY+G +S +AVK L + S+Q E++F E L+
Sbjct: 34 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 93
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+++ H+N+VR +G L+ R ++ E + L F+
Sbjct: 94 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 131
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSKN-SKQGEIEFKNEVLL 293
V N + LG G FG VY+G +S +AVK L + S+Q E++F E L+
Sbjct: 54 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 113
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+++ H+N+VR +G L+ R ++ E + L F+
Sbjct: 114 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 151
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 251 KLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
+LG+G FG V+ N +AVK L + S+ +F+ E LL LQH+++VR
Sbjct: 25 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 305 LLGFCLERKERILVYEFVPNASLDHFI 331
G C E + ++V+E++ + L+ F+
Sbjct: 85 FFGVCTEGRPLLMVFEYMRHGDLNRFL 111
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 251 KLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
+LG+G FG V+ N +AVK L + S+ +F+ E LL LQH+++VR
Sbjct: 19 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 305 LLGFCLERKERILVYEFVPNASLDHFI 331
G C E + ++V+E++ + L+ F+
Sbjct: 79 FFGVCTEGRPLLMVFEYMRHGDLNRFL 105
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 251 KLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
+LG+G FG V+ N +AVK L + S+ +F+ E LL LQH+++VR
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 305 LLGFCLERKERILVYEFVPNASLDHFI 331
G C E + ++V+E++ + L+ F+
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFL 134
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 31/88 (35%), Positives = 52/88 (59%), Gaps = 7/88 (7%)
Query: 251 KLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRL 305
+LG+G FG+V Y + N GE +AVK+L ++++ +F+ E+ +L LQH N+V+
Sbjct: 20 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 306 LGFCLE--RKERILVYEFVPNASLDHFI 331
G C R+ L+ EF+P SL ++
Sbjct: 80 KGVCYSAGRRNLKLIMEFLPYGSLREYL 107
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 28/86 (32%), Positives = 51/86 (59%), Gaps = 6/86 (6%)
Query: 252 LGQGGFGAVYKGML--SNGET---IAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
+G G FG VYKGML S+G+ +A+K L +++ ++F E ++ + H N++RL
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 306 LGFCLERKERILVYEFVPNASLDHFI 331
G + K +++ E++ N +LD F+
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFL 137
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 46/83 (55%), Gaps = 1/83 (1%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
++G G FG V+ G N + +A+K + + S E +F E ++ +L H LV+L G
Sbjct: 32 VQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 309 CLERKERILVYEFVPNASLDHFI 331
CLE+ LV+EF+ + L ++
Sbjct: 91 CLEQAPICLVFEFMEHGCLSDYL 113
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
+LG+G FG+V Y + N GE +AVK+L ++++ +F+ E+ +L LQH N+V+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFI 331
G C R+ L+ E++P SL ++
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 135
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
+LG+G FG+V Y + N GE +AVK+L ++++ +F+ E+ +L LQH N+V+
Sbjct: 19 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFI 331
G C R+ L+ E++P SL ++
Sbjct: 79 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 107
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
+LG+G FG+V Y + N GE +AVK+L ++++ +F+ E+ +L LQH N+V+
Sbjct: 22 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFI 331
G C R+ L+ E++P SL ++
Sbjct: 82 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 110
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
+LG+G FG+V Y + N GE +AVK+L ++++ +F+ E+ +L LQH N+V+
Sbjct: 21 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFI 331
G C R+ L+ E++P SL ++
Sbjct: 81 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 109
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIE-------FKNEVL 292
+A + ++G+GGFG V+KG ++ + +A+K L +GE E F+ EV
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDH 329
+++ L H N+V+L G L +V EFVP L H
Sbjct: 76 IMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYH 110
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIE-------FKNEVL 292
+A + ++G+GGFG V+KG ++ + +A+K L +GE E F+ EV
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDH 329
+++ L H N+V+L G L +V EFVP L H
Sbjct: 76 IMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYH 110
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
+LG+G FG+V Y + N GE +AVK+L ++++ +F+ E+ +L LQH N+V+
Sbjct: 20 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFI 331
G C R+ L+ E++P SL ++
Sbjct: 80 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 108
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
+LG+G FG+V Y + N GE +AVK+L ++++ +F+ E+ +L LQH N+V+
Sbjct: 14 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFI 331
G C R+ L+ E++P SL ++
Sbjct: 74 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 102
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
+LG+G FG+V Y + N GE +AVK+L ++++ +F+ E+ +L LQH N+V+
Sbjct: 23 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFI 331
G C R+ L+ E++P SL ++
Sbjct: 83 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 111
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
+LG+G FG+V Y + N GE +AVK+L ++++ +F+ E+ +L LQH N+V+
Sbjct: 15 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFI 331
G C R+ L+ E++P SL ++
Sbjct: 75 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 103
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
+LG+G FG+V Y + N GE +AVK+L ++++ +F+ E+ +L LQH N+V+
Sbjct: 17 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFI 331
G C R+ L+ E++P SL ++
Sbjct: 77 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 105
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
+LG+G FG+V Y + N GE +AVK+L ++++ +F+ E+ +L LQH N+V+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFI 331
G C R+ L+ E++P SL ++
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIE-------FKNEVL 292
+A + ++G+GGFG V+KG ++ + +A+K L +GE E F+ EV
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDH 329
+++ L H N+V+L G L +V EFVP L H
Sbjct: 76 IMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYH 110
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
+LG+G FG+V Y + N GE +AVK+L ++++ +F+ E+ +L LQH N+V+
Sbjct: 19 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFI 331
G C R+ L+ E++P SL ++
Sbjct: 79 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 107
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
+LG+G FG+V Y + N GE +AVK+L ++++ +F+ E+ +L LQH N+V+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFI 331
G C R+ L+ E++P SL ++
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
+LG+G FG+V Y + N GE +AVK+L ++++ +F+ E+ +L LQH N+V+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFI 331
G C R+ L+ E++P SL ++
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 52/88 (59%), Gaps = 7/88 (7%)
Query: 251 KLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRL 305
+LG+G FG+V Y + N GE +AVK+L ++++ +F+ E+ +L LQH N+V+
Sbjct: 35 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 306 LGFCLE--RKERILVYEFVPNASLDHFI 331
G C R+ L+ E++P SL ++
Sbjct: 95 KGVCYSAGRRNLKLIMEYLPYGSLRDYL 122
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
+LG+G FG+V Y + N GE +AVK+L ++++ +F+ E+ +L LQH N+V+
Sbjct: 34 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFI 331
G C R+ L+ E++P SL ++
Sbjct: 94 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 122
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 46/83 (55%), Gaps = 1/83 (1%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
++G G FG V+ G N + +A+K + + + E +F E ++ +L H LV+L G
Sbjct: 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGV 68
Query: 309 CLERKERILVYEFVPNASLDHFI 331
CLE+ LV+EF+ + L ++
Sbjct: 69 CLEQAPICLVFEFMEHGCLSDYL 91
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 46/83 (55%), Gaps = 1/83 (1%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
++G G FG V+ G N + +A+K + + + E +F E ++ +L H LV+L G
Sbjct: 12 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGV 70
Query: 309 CLERKERILVYEFVPNASLDHFI 331
CLE+ LV+EF+ + L ++
Sbjct: 71 CLEQAPICLVFEFMEHGCLSDYL 93
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 46/83 (55%), Gaps = 1/83 (1%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
++G G FG V+ G N + +A+K + + + E +F E ++ +L H LV+L G
Sbjct: 12 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGV 70
Query: 309 CLERKERILVYEFVPNASLDHFI 331
CLE+ LV+EF+ + L ++
Sbjct: 71 CLEQAPICLVFEFMEHGCLSDYL 93
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 46/83 (55%), Gaps = 1/83 (1%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
++G G FG V+ G N + +A+K + + + E +F E ++ +L H LV+L G
Sbjct: 15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGV 73
Query: 309 CLERKERILVYEFVPNASLDHFI 331
CLE+ LV+EF+ + L ++
Sbjct: 74 CLEQAPICLVFEFMEHGCLSDYL 96
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 29/83 (34%), Positives = 48/83 (57%), Gaps = 2/83 (2%)
Query: 250 NKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
+KLG G FG VY+G+ T+AVK L +++ + E EF E ++ ++H NLV+LLG
Sbjct: 17 HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 75
Query: 309 CLERKERILVYEFVPNASLDHFI 331
C ++ EF+ +L ++
Sbjct: 76 CTREPPFYIITEFMTYGNLLDYL 98
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 29/83 (34%), Positives = 48/83 (57%), Gaps = 2/83 (2%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
+KLG G +G VY G+ T+AVK L +++ + E EF E ++ ++H NLV+LLG
Sbjct: 38 HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 96
Query: 309 CLERKERILVYEFVPNASLDHFI 331
C +V E++P +L ++
Sbjct: 97 CTLEPPFYIVTEYMPYGNLLDYL 119
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 6/98 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLL 293
+ N +LG+G FG V+ N +AVK L S +F E L
Sbjct: 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL 68
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
L LQH ++V+ G C+E I+V+E++ + L+ F+
Sbjct: 69 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL 106
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 9 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 68 MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL 105
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 9 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 68 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 105
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 5 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 63
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 64 MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL 101
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 66
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 104
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 9 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 68 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 105
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL 100
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 5 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 63
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 64 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 101
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL 100
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 9 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 68 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 105
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 9 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 68 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 105
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 6 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 64
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 65 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 102
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 48/83 (57%), Gaps = 2/83 (2%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
+KLG G +G VY+G+ T+AVK L +++ + E EF E ++ ++H NLV+LLG
Sbjct: 17 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 75
Query: 309 CLERKERILVYEFVPNASLDHFI 331
C ++ EF+ +L ++
Sbjct: 76 CTREPPFYIIIEFMTYGNLLDYL 98
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 30/91 (32%), Positives = 51/91 (56%), Gaps = 9/91 (9%)
Query: 251 KLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNL 302
+LG+ FG VYKG L + +A+K L K+ +G + EF++E +L ARLQH N+
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
V LLG + + +++ + + L F+ +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVM 105
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 30/91 (32%), Positives = 51/91 (56%), Gaps = 9/91 (9%)
Query: 251 KLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNL 302
+LG+ FG VYKG L + +A+K L K+ +G + EF++E +L ARLQH N+
Sbjct: 33 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
V LLG + + +++ + + L F+ +
Sbjct: 92 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVM 122
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 17 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 75
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 76 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 113
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 6 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 64
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 65 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 102
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 6 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 64
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 65 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 102
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 45/83 (54%), Gaps = 1/83 (1%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
++G G FG V+ G N + +A+K + + + E +F E ++ +L H LV+L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGV 71
Query: 309 CLERKERILVYEFVPNASLDHFI 331
CLE+ LV EF+ + L ++
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYL 94
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 269
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 307
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 48/83 (57%), Gaps = 2/83 (2%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
+KLG G +G VY+G+ T+AVK L +++ + E EF E ++ ++H NLV+LLG
Sbjct: 17 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 75
Query: 309 CLERKERILVYEFVPNASLDHFI 331
C ++ EF+ +L ++
Sbjct: 76 CTREPPFYIITEFMTYGNLLDYL 98
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 208 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 266
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 267 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 304
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
+++ + + + +KLG G +G VY+G+ T+AVK L +++ + E EF E +
Sbjct: 250 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 308
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++H NLV+LLG C ++ EF+ +L ++
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 346
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 4/87 (4%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRN 301
FSD ++G G FGAVY + N E +A+K++S + KQ ++++ EV L +L+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 302 LVRLLGFCLERKERILVYEFVPNASLD 328
++ G L LV E+ ++ D
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD 103
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 4/87 (4%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRN 301
FSD ++G G FGAVY + N E +A+K++S + KQ ++++ EV L +L+H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 302 LVRLLGFCLERKERILVYEFVPNASLD 328
++ G L LV E+ ++ D
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD 142
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 47.8 bits (112), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 40/83 (48%), Gaps = 1/83 (1%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
KLG G FG V+ G +N +AVK L + + F E L+ LQH LVRL
Sbjct: 17 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-AFLEEANLMKTLQHDKLVRLYAV 75
Query: 309 CLERKERILVYEFVPNASLDHFI 331
+ + ++ EF+ SL F+
Sbjct: 76 VTKEEPIYIITEFMAKGSLLDFL 98
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 27/86 (31%), Positives = 44/86 (51%), Gaps = 3/86 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ D + KLG+G +G VYK + + ET+A+KR+ ++ + EV LL LQ
Sbjct: 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 299 HRNLVRLLGFCLERKERILVYEFVPN 324
HRN++ L L++E+ N
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEN 117
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 30/97 (30%), Positives = 47/97 (48%), Gaps = 4/97 (4%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNS--KQG-EIEFKNE 290
D T D+F LG+G FG VY +A+K L K+ K+G E + + E
Sbjct: 14 DILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRRE 73
Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL 327
+ + A L H N++RL + +R+ L+ E+ P L
Sbjct: 74 IEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGEL 110
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 2/85 (2%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQH 299
++ F KLG G + VYKG+ + G +A+K + +S++G E+ L+ L+H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 300 RNLVRLLGFCLERKERILVYEFVPN 324
N+VRL + LV+EF+ N
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDN 87
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 27/98 (27%), Positives = 45/98 (45%), Gaps = 1/98 (1%)
Query: 234 FDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLL 293
+D + + ++ +LG G FG V+ G +N +AVK L + + F E L
Sbjct: 3 WDKDAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-AFLEEANL 61
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ LQH LVRL + ++ E++ SL F+
Sbjct: 62 MKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFL 99
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 3/90 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRL--SKNSKQGEIEFKNEVLLLARLQ 298
+ + + + +G+G +G V K + G +A+K+ S + K + E+ LL +L+
Sbjct: 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLD 328
H NLV LL C ++K LV+EFV + LD
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDHTILD 112
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 6/85 (7%)
Query: 252 LGQGGFGAVYKGMLSN--GETI--AVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL 306
LG+G FG VY+G+ +N GE I AVK K+ E F +E +++ L H ++V+L+
Sbjct: 16 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 307 GFCLERKERILVYEFVPNASLDHFI 331
G +E + ++ E P L H++
Sbjct: 76 GI-IEEEPTWIIMELYPYGELGHYL 99
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 6/85 (7%)
Query: 252 LGQGGFGAVYKGMLSN--GETI--AVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL 306
LG+G FG VY+G+ +N GE I AVK K+ E F +E +++ L H ++V+L+
Sbjct: 32 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 307 GFCLERKERILVYEFVPNASLDHFI 331
G +E + ++ E P L H++
Sbjct: 92 GI-IEEEPTWIIMELYPYGELGHYL 115
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 6/85 (7%)
Query: 252 LGQGGFGAVYKGMLSN--GETI--AVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL 306
LG+G FG VY+G+ +N GE I AVK K+ E F +E +++ L H ++V+L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 307 GFCLERKERILVYEFVPNASLDHFI 331
G +E + ++ E P L H++
Sbjct: 80 GI-IEEEPTWIIMELYPYGELGHYL 103
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARL 297
V +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 4 VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 298 QHRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+EF+
Sbjct: 64 NHPNIVKLLDVIHTENKLYLVFEFL 88
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ ++ + FKN E+ ++ +L H N+
Sbjct: 49 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 103
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVP 130
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ ++ + FKN E+ ++ +L H N+
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 109
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVP 136
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ ++ + FKN E+ ++ +L H N+
Sbjct: 57 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 111
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVP 138
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ ++ + FKN E+ ++ +L H N+
Sbjct: 59 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 113
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVP 140
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ ++ + FKN E+ ++ +L H N+
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 109
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVP 136
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ ++ + FKN E+ ++ +L H N+
Sbjct: 26 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 80
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 81 VRLRYFFYSSGEKKDEVYLNLVLDYVP 107
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ ++ + FKN E+ ++ +L H N+
Sbjct: 34 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 88
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 89 VRLRYFFYSSGEKKDEVYLNLVLDYVP 115
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ ++ + FKN E+ ++ +L H N+
Sbjct: 40 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 94
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 95 VRLRYFFYSSGEKKDEVYLNLVLDYVP 121
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ ++ + FKN E+ ++ +L H N+
Sbjct: 29 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 83
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 84 VRLRYFFYSSGEKKDEVYLNLVLDYVP 110
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ ++ + FKN E+ ++ +L H N+
Sbjct: 33 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 87
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 88 VRLRYFFYSSGEKKDEVYLNLVLDYVP 114
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 299 HRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+EF+
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL 86
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 299 HRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+EF+
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL 86
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 299 HRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+EF+
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL 84
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ ++ + FKN E+ ++ +L H N+
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 154
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVP 181
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ ++ + FKN E+ ++ +L H N+
Sbjct: 33 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 87
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 88 VRLRYFFYSSGEKKDEVYLNLVLDYVP 114
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 299 HRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+EF+
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL 84
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ ++ + FKN E+ ++ +L H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVP 102
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 299 HRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+EF+
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL 87
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ ++ + FKN E+ ++ +L H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVP 102
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 299 HRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+EF+
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL 87
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 299 HRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+EF+
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL 86
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ ++ + FKN E+ ++ +L H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVP 102
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 299 HRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+EF+
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL 87
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 299 HRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+EF+
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL 84
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 299 HRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+EF+
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL 84
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 299 HRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+EF+
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFL 85
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 299 HRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+EF+
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL 87
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRN 301
+ + K+G+G +G VYK + GET A+K RL K + E+ +L L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 302 LVRLLGFCLERKERILVYEFV 322
+V+L +K +LV+E +
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHL 82
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ ++ + FKN E+ ++ +L H N+
Sbjct: 22 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 76
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 77 VRLRYFFYSSGEKKDEVYLNLVLDYVP 103
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 299 HRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+EF+
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFL 85
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 299 HRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+EF+
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFL 85
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 299 HRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+EF+
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL 87
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRN 301
+ + K+G+G +G VYK + GET A+K RL K + E+ +L L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 302 LVRLLGFCLERKERILVYEFV 322
+V+L +K +LV+E +
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHL 82
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ ++ + FKN E+ ++ +L H N+
Sbjct: 25 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 79
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 80 VRLRYFFYSSGEKKDEVYLNLVLDYVP 106
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 299 HRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+EF+
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL 86
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 299 HRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+EF+
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFL 85
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 32/101 (31%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNE 290
L++D+E D D LG+G +G VY G LSN IA+K + + + E
Sbjct: 15 LEYDYEY-----DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEE 69
Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ L L+H+N+V+ LG E + E VP SL +
Sbjct: 70 IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL 110
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRN 301
+ + K+G+G +G VYK + GET A+K RL K + E+ +L L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 302 LVRLLGFCLERKERILVYEFV 322
+V+L +K +LV+E +
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHL 82
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 26/87 (29%), Positives = 44/87 (50%), Gaps = 6/87 (6%)
Query: 251 KLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
+LG+G FG V+ N +AVK L + +F+ E LL LQH ++V+
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 305 LLGFCLERKERILVYEFVPNASLDHFI 331
G C + I+V+E++ + L+ F+
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFL 108
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 5 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 299 HRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+EF+
Sbjct: 65 HPNIVKLLDVIHTENKLYLVFEFL 88
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 3/82 (3%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
+NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 301 NLVRLLGFCLERKERILVYEFV 322
N+V+LL + LV+EF+
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 3/82 (3%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
+NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 301 NLVRLLGFCLERKERILVYEFV 322
N+V+LL + LV+EF+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 3/82 (3%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
+NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 301 NLVRLLGFCLERKERILVYEFV 322
N+V+LL + LV+EF+
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 3/82 (3%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
+NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 301 NLVRLLGFCLERKERILVYEFV 322
N+V+LL + LV+EF+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 3/82 (3%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
+NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 301 NLVRLLGFCLERKERILVYEFV 322
N+V+LL + LV+EF+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 3/82 (3%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
+NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L H
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 301 NLVRLLGFCLERKERILVYEFV 322
N+V+LL + LV+EF+
Sbjct: 70 NIVKLLDVIHTENKLYLVFEFL 91
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 49/95 (51%), Gaps = 7/95 (7%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSNG--ETIAVKRLSKN-SKQGEIEFKNEVLLLAR 296
+N +G+G FG V++ G+L +AVK L + S + +F+ E L+A
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ N+V+LLG C K L++E++ L+ F+
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL 141
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 3/82 (3%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
+NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 301 NLVRLLGFCLERKERILVYEFV 322
N+V+LL + LV+EF+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 299 HRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+EF+
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL 84
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 3/82 (3%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
+NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L H
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 301 NLVRLLGFCLERKERILVYEFV 322
N+V+LL + LV+EF+
Sbjct: 70 NIVKLLDVIHTENKLYLVFEFL 91
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 3/82 (3%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
+NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 301 NLVRLLGFCLERKERILVYEFV 322
N+V+LL + LV+EF+
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 51/86 (59%), Gaps = 6/86 (6%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
+G+G FG VY G L ++G+ I AVK L++ + GE+ +F E +++ H N++ LL
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI 331
G CL + ++V ++ + L +FI
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFI 182
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 3/82 (3%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
+NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 301 NLVRLLGFCLERKERILVYEFV 322
N+V+LL + LV+EF+
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 3/82 (3%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
+NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L H
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 301 NLVRLLGFCLERKERILVYEFV 322
N+V+LL + LV+EF+
Sbjct: 64 NIVKLLDVIHTENKLYLVFEFL 85
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
V + +LG G FG V+ G + +AVK L + S + F E L+ +LQH+
Sbjct: 16 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 74
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFI 331
LVRL + I+ E++ N SL F+
Sbjct: 75 RLVRLYAVVTQEPIYIIT-EYMENGSLVDFL 104
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
V + +LG G FG V+ G + +AVK L + S + F E L+ +LQH+
Sbjct: 19 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 77
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFI 331
LVRL + I+ E++ N SL F+
Sbjct: 78 RLVRLYAVVTQEPIYIIT-EYMENGSLVDFL 107
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
V + +LG G FG V+ G + +AVK L + S + F E L+ +LQH+
Sbjct: 20 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 78
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFI 331
LVRL + I+ E++ N SL F+
Sbjct: 79 RLVRLYAVVTQEPIYIIT-EYMENGSLVDFL 108
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
V + +LG G FG V+ G + +AVK L + S + F E L+ +LQH+
Sbjct: 18 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQ 76
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFI 331
LVRL + I+ E++ N SL F+
Sbjct: 77 RLVRLYAVVTQEPIYIIT-EYMENGSLVDFL 106
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 6/97 (6%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNE 290
L++D+E D D LG+G +G VY G LSN IA+K + + + E
Sbjct: 1 LEYDYEY-----DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEE 55
Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL 327
+ L L+H+N+V+ LG E + E VP SL
Sbjct: 56 IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 92
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
V + +LG G FG V+ G + +AVK L + S + F E L+ +LQH+
Sbjct: 16 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 74
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFI 331
LVRL + I+ E++ N SL F+
Sbjct: 75 RLVRLYAVVTQEPIYIIT-EYMENGSLVDFL 104
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
V + +LG G FG V+ G + +AVK L + S + F E L+ +LQH+
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 68
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFI 331
LVRL + I+ E++ N SL F+
Sbjct: 69 RLVRLYAVVTQEPIYIIT-EYMENGSLVDFL 98
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
V + +LG G FG V+ G + +AVK L + S + F E L+ +LQH+
Sbjct: 15 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 73
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFI 331
LVRL + I+ E++ N SL F+
Sbjct: 74 RLVRLYAVVTQEPIYIIT-EYMENGSLVDFL 103
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
V + +LG G FG V+ G + +AVK L + S + F E L+ +LQH+
Sbjct: 12 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 70
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFI 331
LVRL + I+ E++ N SL F+
Sbjct: 71 RLVRLYAVVTQEPIYIIT-EYMENGSLVDFL 100
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 51/86 (59%), Gaps = 6/86 (6%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
+G+G FG VY G L ++G+ I AVK L++ + GE+ +F E +++ H N++ LL
Sbjct: 57 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI 331
G CL + ++V ++ + L +FI
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFI 142
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 51/86 (59%), Gaps = 6/86 (6%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
+G+G FG VY G L ++G+ I AVK L++ + GE+ +F E +++ H N++ LL
Sbjct: 38 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI 331
G CL + ++V ++ + L +FI
Sbjct: 98 GICLRSEGSPLVVLPYMKHGDLRNFI 123
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 45.1 bits (105), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 51/86 (59%), Gaps = 6/86 (6%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
+G+G FG VY G L ++G+ I AVK L++ + GE+ +F E +++ H N++ LL
Sbjct: 37 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI 331
G CL + ++V ++ + L +FI
Sbjct: 97 GICLRSEGSPLVVLPYMKHGDLRNFI 122
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 45.1 bits (105), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ ++ + FKN E+ ++ +L H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 76 VRLRYFFYSSGEKKDVVYLNLVLDYVP 102
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 45.1 bits (105), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
V + +LG G FG V+ G + +AVK L + S + F E L+ +LQH+
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 68
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFI 331
LVRL + I+ E++ N SL F+
Sbjct: 69 RLVRLYAVVTQEPIYIIT-EYMENGSLVDFL 98
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 45.1 bits (105), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 51/86 (59%), Gaps = 6/86 (6%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
+G+G FG VY G L ++G+ I AVK L++ + GE+ +F E +++ H N++ LL
Sbjct: 43 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI 331
G CL + ++V ++ + L +FI
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFI 128
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 45.1 bits (105), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 51/86 (59%), Gaps = 6/86 (6%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
+G+G FG VY G L ++G+ I AVK L++ + GE+ +F E +++ H N++ LL
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI 331
G CL + ++V ++ + L +FI
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFI 118
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 45.1 bits (105), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 51/86 (59%), Gaps = 6/86 (6%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
+G+G FG VY G L ++G+ I AVK L++ + GE+ +F E +++ H N++ LL
Sbjct: 56 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI 331
G CL + ++V ++ + L +FI
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFI 141
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 45.1 bits (105), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
V + +LG G FG V+ G + +AVK L + S + F E L+ +LQH+
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 68
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFI 331
LVRL + I+ E++ N SL F+
Sbjct: 69 RLVRLYAVVTQEPIYIIT-EYMENGSLVDFL 98
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 45.1 bits (105), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
V + +LG G FG V+ G + +AVK L + S + F E L+ +LQH+
Sbjct: 11 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 69
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFI 331
LVRL + I+ E++ N SL F+
Sbjct: 70 RLVRLYAVVTQEPIYIIT-EYMENGSLVDFL 99
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 45.1 bits (105), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 51/86 (59%), Gaps = 6/86 (6%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
+G+G FG VY G L ++G+ I AVK L++ + GE+ +F E +++ H N++ LL
Sbjct: 37 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI 331
G CL + ++V ++ + L +FI
Sbjct: 97 GICLRSEGSPLVVLPYMKHGDLRNFI 122
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 45.1 bits (105), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 51/86 (59%), Gaps = 6/86 (6%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
+G+G FG VY G L ++G+ I AVK L++ + GE+ +F E +++ H N++ LL
Sbjct: 36 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI 331
G CL + ++V ++ + L +FI
Sbjct: 96 GICLRSEGSPLVVLPYMKHGDLRNFI 121
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 45.1 bits (105), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 51/86 (59%), Gaps = 6/86 (6%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
+G+G FG VY G L ++G+ I AVK L++ + GE+ +F E +++ H N++ LL
Sbjct: 38 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI 331
G CL + ++V ++ + L +FI
Sbjct: 98 GICLRSEGSPLVVLPYMKHGDLRNFI 123
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 45.1 bits (105), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 51/86 (59%), Gaps = 6/86 (6%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
+G+G FG VY G L ++G+ I AVK L++ + GE+ +F E +++ H N++ LL
Sbjct: 38 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI 331
G CL + ++V ++ + L +FI
Sbjct: 98 GICLRSEGSPLVVLPYMKHGDLRNFI 123
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 45.1 bits (105), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 51/86 (59%), Gaps = 6/86 (6%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
+G+G FG VY G L ++G+ I AVK L++ + GE+ +F E +++ H N++ LL
Sbjct: 38 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI 331
G CL + ++V ++ + L +FI
Sbjct: 98 GICLRSEGSPLVVLPYMKHGDLRNFI 123
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 45.1 bits (105), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 51/86 (59%), Gaps = 6/86 (6%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
+G+G FG VY G L ++G+ I AVK L++ + GE+ +F E +++ H N++ LL
Sbjct: 39 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI 331
G CL + ++V ++ + L +FI
Sbjct: 99 GICLRSEGSPLVVLPYMKHGDLRNFI 124
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 45.1 bits (105), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 51/86 (59%), Gaps = 6/86 (6%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
+G+G FG VY G L ++G+ I AVK L++ + GE+ +F E +++ H N++ LL
Sbjct: 30 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI 331
G CL + ++V ++ + L +FI
Sbjct: 90 GICLRSEGSPLVVLPYMKHGDLRNFI 115
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 45.1 bits (105), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
V + +LG G FG V+ G + +AVK L + S + F E L+ +LQH+
Sbjct: 6 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFI 331
LVRL + I+ E++ N SL F+
Sbjct: 65 RLVRLYAVVTQEPIYIIT-EYMENGSLVDFL 94
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 45.1 bits (105), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 51/86 (59%), Gaps = 6/86 (6%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
+G+G FG VY G L ++G+ I AVK L++ + GE+ +F E +++ H N++ LL
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI 331
G CL + ++V ++ + L +FI
Sbjct: 95 GICLRSEGSPLVVLPYMKHGDLRNFI 120
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 45.1 bits (105), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 51/86 (59%), Gaps = 6/86 (6%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
+G+G FG VY G L ++G+ I AVK L++ + GE+ +F E +++ H N++ LL
Sbjct: 36 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI 331
G CL + ++V ++ + L +FI
Sbjct: 96 GICLRSEGSPLVVLPYMKHGDLRNFI 121
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 45.1 bits (105), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLA 295
+ D+F LG+G FG VY + I A+K L K+ K+G E + + E+ + +
Sbjct: 10 KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASL 327
L+H N++R+ + +RK L+ EF P L
Sbjct: 70 HLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL 101
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 45.1 bits (105), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 51/86 (59%), Gaps = 6/86 (6%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
+G+G FG VY G L ++G+ I AVK L++ + GE+ +F E +++ H N++ LL
Sbjct: 39 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI 331
G CL + ++V ++ + L +FI
Sbjct: 99 GICLRSEGSPLVVLPYMKHGDLRNFI 124
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 45.1 bits (105), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
V + +LG G FG V+ G + +AVK L + S + F E L+ +LQH+
Sbjct: 5 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 63
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFI 331
LVRL + I+ E++ N SL F+
Sbjct: 64 RLVRLYAVVTQEPIYIIT-EYMENGSLVDFL 93
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 45.1 bits (105), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLA 295
+ D+F LG+G FG VY + I A+K L K+ K+G E + + E+ + +
Sbjct: 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASL 327
L+H N++R+ + +RK L+ EF P L
Sbjct: 70 HLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL 101
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 45.1 bits (105), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLA 295
+ D+F LG+G FG VY + I A+K L K+ K+G E + + E+ + +
Sbjct: 11 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 70
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASL 327
L+H N++R+ + +RK L+ EF P L
Sbjct: 71 HLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL 102
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 45.1 bits (105), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 25/81 (30%), Positives = 42/81 (51%), Gaps = 2/81 (2%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHRN 301
+ + K+G+G +G VYK S G +A+KR+ +++ I E+ LL L H N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 302 LVRLLGFCLERKERILVYEFV 322
+V L+ + LV+EF+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFM 101
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 45.1 bits (105), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 25/81 (30%), Positives = 42/81 (51%), Gaps = 2/81 (2%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHRN 301
+ + K+G+G +G VYK S G +A+KR+ +++ I E+ LL L H N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 302 LVRLLGFCLERKERILVYEFV 322
+V L+ + LV+EF+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFM 101
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 44.7 bits (104), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 24/82 (29%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
+LG G FG V G +A+K + + S E EF E ++ L H LV+L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 310 LERKERILVYEFVPNASLDHFI 331
+++ ++ E++ N L +++
Sbjct: 89 TKQRPIFIITEYMANGCLLNYL 110
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 44.7 bits (104), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 24/82 (29%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
+LG G FG V G +A+K + + S E EF E ++ L H LV+L G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 310 LERKERILVYEFVPNASLDHFI 331
+++ ++ E++ N L +++
Sbjct: 69 TKQRPIFIITEYMANGCLLNYL 90
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 44.7 bits (104), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 24/82 (29%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
+LG G FG V G +A+K + + S E EF E ++ L H LV+L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 310 LERKERILVYEFVPNASLDHFI 331
+++ ++ E++ N L +++
Sbjct: 89 TKQRPIFIITEYMANGCLLNYL 110
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 44.7 bits (104), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 24/82 (29%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
+LG G FG V G +A+K + + S E EF E ++ L H LV+L G C
Sbjct: 14 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 310 LERKERILVYEFVPNASLDHFI 331
+++ ++ E++ N L +++
Sbjct: 73 TKQRPIFIITEYMANGCLLNYL 94
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 44.7 bits (104), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 24/82 (29%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
+LG G FG V G +A+K + + S E EF E ++ L H LV+L G C
Sbjct: 21 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 310 LERKERILVYEFVPNASLDHFI 331
+++ ++ E++ N L +++
Sbjct: 80 TKQRPIFIITEYMANGCLLNYL 101
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 44.7 bits (104), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 24/82 (29%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
+LG G FG V G +A+K + + S E EF E ++ L H LV+L G C
Sbjct: 15 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 310 LERKERILVYEFVPNASLDHFI 331
+++ ++ E++ N L +++
Sbjct: 74 TKQRPIFIITEYMANGCLLNYL 95
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 31/87 (35%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ QG+ FKN E+ ++ +L H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGK-AFKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVP 102
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 31/87 (35%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ QG+ FKN E+ ++ +L H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGK-AFKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVP 102
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 24/82 (29%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
+LG G FG V G +A+K + + S E EF E ++ L H LV+L G C
Sbjct: 15 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 310 LERKERILVYEFVPNASLDHFI 331
+++ ++ E++ N L +++
Sbjct: 74 TKQRPIFIITEYMANGCLLNYL 95
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 31/87 (35%), Positives = 52/87 (59%), Gaps = 13/87 (14%)
Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
+++D +G G FG VY+ L +GE +A+K++ QG+ FKN E+ ++ +L H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGK-AFKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVP 323
VRL F E+K+ + LV ++VP
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVP 102
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 44.3 bits (103), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 44/84 (52%), Gaps = 3/84 (3%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
+ +NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 299 HRNLVRLLGFCLERKERILVYEFV 322
H N+V+LL + LV+E V
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEHV 87
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 43/82 (52%), Gaps = 3/82 (3%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
+NF K+G+G +G VYK GE +A+K++ +++ + E+ LL L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 301 NLVRLLGFCLERKERILVYEFV 322
N+V+LL + LV+E V
Sbjct: 62 NIVKLLDVIHTENKLYLVFEHV 83
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/114 (23%), Positives = 54/114 (47%), Gaps = 3/114 (2%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKN 279
ED N +T+ + D + + ++G G FG VYKG + + ++
Sbjct: 14 EDRNRMKTLGRRDSSD--DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP 71
Query: 280 SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+ Q FKNEV +L + +H N++ +G+ + + +V ++ +SL H + +
Sbjct: 72 TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHI 124
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGML-----SNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
VA + + + +LGQG FG VY+G+ ET +A+K +++ + E IEF NE +
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++VRLLG + + +++ E + L ++
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/114 (23%), Positives = 54/114 (47%), Gaps = 3/114 (2%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKN 279
ED N +T+ + D + + ++G G FG VYKG + + ++
Sbjct: 13 EDRNRMKTLGRRDSSD--DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP 70
Query: 280 SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+ Q FKNEV +L + +H N++ +G+ + + +V ++ +SL H + +
Sbjct: 71 TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHI 123
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGML-----SNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
VA + + + +LGQG FG VY+G+ ET +A+K +++ + E IEF NE +
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++VRLLG + + +++ E + L ++
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/114 (23%), Positives = 54/114 (47%), Gaps = 3/114 (2%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKN 279
ED N +T+ + D + + ++G G FG VYKG + + ++
Sbjct: 14 EDRNRMKTLGRRDSSD--DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP 71
Query: 280 SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+ Q FKNEV +L + +H N++ +G+ + + +V ++ +SL H + +
Sbjct: 72 TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHI 124
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
VA + + + +LGQG FG VY+G+ ET +A+K +++ + E IEF NE +
Sbjct: 15 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++VRLLG + + +++ E + L ++
Sbjct: 75 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 112
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
VA + + + +LGQG FG VY+G+ ET +A+K +++ + E IEF NE +
Sbjct: 15 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++VRLLG + + +++ E + L ++
Sbjct: 75 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 112
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 252 LGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRL 305
LG+G FG V Y N GE +AVK L S I + K E+ +L L H N+V+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 306 LGFCLERKER--ILVYEFVPNASLDHFI 331
G C E L+ EF+P+ SL ++
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYL 116
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
VA + + + +LGQG FG VY+G+ ET +A+K +++ + E IEF NE +
Sbjct: 13 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 72
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++VRLLG + + +++ E + L ++
Sbjct: 73 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 110
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
VA + + + +LGQG FG VY+G+ ET +A+K +++ + E IEF NE +
Sbjct: 9 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++VRLLG + + +++ E + L ++
Sbjct: 69 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 106
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
VA + + + +LGQG FG VY+G+ ET +A+K +++ + E IEF NE +
Sbjct: 9 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++VRLLG + + +++ E + L ++
Sbjct: 69 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 106
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
VA + + + +LGQG FG VY+G+ ET +A+K +++ + E IEF NE +
Sbjct: 16 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++VRLLG + + +++ E + L ++
Sbjct: 76 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 113
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
VA + + + +LGQG FG VY+G+ ET +A+K +++ + E IEF NE +
Sbjct: 12 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 71
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++VRLLG + + +++ E + L ++
Sbjct: 72 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 109
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGML-----SNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
VA + + + +LGQG FG VY+G+ ET +A+K +++ + E IEF NE +
Sbjct: 7 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++VRLLG + + +++ E + L ++
Sbjct: 67 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 104
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
VA + + + +LGQG FG VY+G+ ET +A+K +++ + E IEF NE +
Sbjct: 16 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++VRLLG + + +++ E + L ++
Sbjct: 76 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 113
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 9/103 (8%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
DN +G+G +GAVYKG L + +AVK S ++Q I KN + + ++H N+
Sbjct: 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKN-IYRVPLMEHDNIA 70
Query: 304 RLL-----GFCLERKERILVYEFVPNASLDHFIFVGI--WLQS 339
R + R E +LV E+ PN SL ++ + W+ S
Sbjct: 71 RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSS 113
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 252 LGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRL 305
LG+G FG V Y N GE +AVK L S I + K E+ +L L H N+V+
Sbjct: 17 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 306 LGFCLERKER--ILVYEFVPNASLDHFI 331
G C E L+ EF+P+ SL ++
Sbjct: 77 KGICTEDGGNGIKLIMEFLPSGSLKEYL 104
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 6/89 (6%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE----TIAVKRLS-KNSKQG 283
++ LQ E + + + LG+G FG+V +G L + +AVK + NS Q
Sbjct: 19 SEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR 78
Query: 284 EIE-FKNEVLLLARLQHRNLVRLLGFCLE 311
EIE F +E + H N++RLLG C+E
Sbjct: 79 EIEEFLSEAACMKDFSHPNVIRLLGVCIE 107
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
N S +G G FG V G L S E ++A+K L +++ +F E ++ + H
Sbjct: 17 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
N++RL G + K ++V E++ N SLD F+
Sbjct: 77 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 108
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 43/82 (52%), Gaps = 3/82 (3%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
+NF K+G+G +G VYK GE +A+ ++ +++ + E+ LL L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 301 NLVRLLGFCLERKERILVYEFV 322
N+V+LL + LV+EF+
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 43/82 (52%), Gaps = 3/82 (3%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
+NF K+G+G +G VYK GE +A+ ++ +++ + E+ LL L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 301 NLVRLLGFCLERKERILVYEFV 322
N+V+LL + LV+EF+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
VA + + + +LGQG FG VY+G+ ET +A+K +++ + E IEF NE +
Sbjct: 44 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 103
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++VRLLG + + +++ E + L ++
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 141
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
N S +G G FG V G L S E ++A+K L +++ +F E ++ + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
N++RL G + K ++V E++ N SLD F+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
N S +G G FG V G L S E ++A+K L +++ +F E ++ + H
Sbjct: 34 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
N++RL G + K ++V E++ N SLD F+
Sbjct: 94 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 125
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
N S +G G FG V G L S E ++A+K L +++ +F E ++ + H
Sbjct: 44 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
N++RL G + K ++V E++ N SLD F+
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 135
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
N S +G G FG V G L S E ++A+K L +++ +F E ++ + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
N++RL G + K ++V E++ N SLD F+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
N S +G G FG V G L S E ++A+K L +++ +F E ++ + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
N++RL G + K ++V E++ N SLD F+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
++G G FG VYKG + + ++ + Q FKNEV +L + +H N++ +G+
Sbjct: 18 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 309 CLERKERILVYEFVPNASLDHFIFV 333
+ + +V ++ +SL H + +
Sbjct: 78 S-TKPQLAIVTQWCEGSSLYHHLHI 101
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
++G G FG VYKG + + ++ + Q FKNEV +L + +H N++ +G+
Sbjct: 18 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 309 CLERKERILVYEFVPNASLDHFIFV 333
+ + +V ++ +SL H + +
Sbjct: 78 S-TKPQLAIVTQWCEGSSLYHHLHI 101
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
N S +G G FG V G L S E ++A+K L +++ +F E ++ + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
N++RL G + K ++V E++ N SLD F+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
++G G FG VYKG + + ++ + Q FKNEV +L + +H N++ +G+
Sbjct: 13 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 309 CLERKERILVYEFVPNASLDHFIFV 333
+ + +V ++ +SL H + +
Sbjct: 73 S-TKPQLAIVTQWCEGSSLYHHLHI 96
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
N S +G G FG V G L S E ++A+K L +++ +F E ++ + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
N++RL G + K ++V E++ N SLD F+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
N S +G G FG V G L S E ++A+K L +++ +F E ++ + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
N++RL G + K ++V E++ N SLD F+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
N S +G G FG V G L S E ++A+K L +++ +F E ++ + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
N++RL G + K ++V E++ N SLD F+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
++G G FG VYKG + + ++ + Q FKNEV +L + +H N++ +G+
Sbjct: 15 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 309 CLERKERILVYEFVPNASLDHFIFV 333
+ + +V ++ +SL H + +
Sbjct: 75 S-TKPQLAIVTQWCEGSSLYHHLHI 98
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
++G G FG VYKG + + ++ + Q FKNEV +L + +H N++ +G+
Sbjct: 13 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 309 CLERKERILVYEFVPNASLDHFIFV 333
+ + +V ++ +SL H + +
Sbjct: 73 S-TKPQLAIVTQWCEGSSLYHHLHI 96
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 26/79 (32%), Positives = 41/79 (51%), Gaps = 3/79 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLLGF 308
K+G G FG V++ +G +AVK L + E EF EV ++ RL+H N+V +G
Sbjct: 44 KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 309 CLERKERILVYEFVPNASL 327
+ +V E++ SL
Sbjct: 103 VTQPPNLSIVTEYLSRGSL 121
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
++G G FG VYKG + + ++ + Q FKNEV +L + +H N++ +G+
Sbjct: 33 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 309 CLERKERILVYEFVPNASLDHFIFV 333
+ + +V ++ +SL H + +
Sbjct: 93 S-TKPQLAIVTQWCEGSSLYHHLHI 116
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 236 FETIRVATDNFSDANKLGQGGFGAVYKGM---------LSNGETIAVKRLSKNSKQGEIE 286
F IR F+++ LGQG F ++KG+ L E + +K L K +
Sbjct: 2 FHKIRNEDLIFNES--LGQGTFTKIFKGVRREVGDYGQLHETEVL-LKVLDKAHRNYSES 58
Query: 287 FKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
F ++++L H++LV G C+ E ILV EFV SLD ++
Sbjct: 59 FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL 103
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 26/79 (32%), Positives = 41/79 (51%), Gaps = 3/79 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLLGF 308
K+G G FG V++ +G +AVK L + E EF EV ++ RL+H N+V +G
Sbjct: 44 KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 309 CLERKERILVYEFVPNASL 327
+ +V E++ SL
Sbjct: 103 VTQPPNLSIVTEYLSRGSL 121
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 12/105 (11%)
Query: 236 FETIRVATDNFSDANKLGQGGFGAVYKGM---------LSNGETIAVKRLSKNSKQGEIE 286
F IR F+++ LGQG F ++KG+ L E + +K L K +
Sbjct: 2 FHKIRNEDLIFNES--LGQGTFTKIFKGVRREVGDYGQLHETEVL-LKVLDKAHRNYSES 58
Query: 287 FKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
F ++++L H++LV G C E ILV EFV SLD ++
Sbjct: 59 FFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYL 103
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
V+ + + +LGQG FG VY+G + ET +AVK +++++ E IEF NE +
Sbjct: 14 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++VRLLG + + ++V E + + L ++
Sbjct: 74 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL 111
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
V+ + + +LGQG FG VY+G + ET +AVK +++++ E IEF NE +
Sbjct: 14 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++VRLLG + + ++V E + + L ++
Sbjct: 74 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL 111
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
V+ + + +LGQG FG VY+G + ET +AVK +++++ E IEF NE +
Sbjct: 14 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++VRLLG + + ++V E + + L ++
Sbjct: 74 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL 111
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
V+ + + +LGQG FG VY+G + ET +AVK +++++ E IEF NE +
Sbjct: 14 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++VRLLG + + ++V E + + L ++
Sbjct: 74 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL 111
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
V+ + + +LGQG FG VY+G + ET +AVK +++++ E IEF NE +
Sbjct: 15 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 74
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++VRLLG + + ++V E + + L ++
Sbjct: 75 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL 112
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
V+ + + +LGQG FG VY+G + ET +AVK +++++ E IEF NE +
Sbjct: 14 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++VRLLG + + ++V E + + L ++
Sbjct: 74 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL 111
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
V+ + + +LGQG FG VY+G + ET +AVK +++++ E IEF NE +
Sbjct: 11 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 70
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++VRLLG + + ++V E + + L ++
Sbjct: 71 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL 108
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 42.4 bits (98), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
V+ + + +LGQG FG VY+G + ET +AVK +++++ E IEF NE +
Sbjct: 13 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 72
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++VRLLG + + ++V E + + L ++
Sbjct: 73 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL 110
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 22/83 (26%), Positives = 43/83 (51%), Gaps = 1/83 (1%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
++G G FG VYKG + + ++ + Q FKNEV +L + +H N++ +G+
Sbjct: 17 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 309 CLERKERILVYEFVPNASLDHFI 331
+ + +V ++ +SL H +
Sbjct: 77 S-TKPQLAIVTQWCEGSSLYHHL 98
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 2/81 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
KLGQG FG V+ G + +A+K L + E F E ++ +L+H LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFI 331
E I++ E++ SL F+
Sbjct: 84 EEPIYIVI-EYMSKGSLLDFL 103
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 2/81 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
KLGQG FG V+ G + +A+K L + E F E ++ +L+H LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFI 331
E I++ E++ SL F+
Sbjct: 84 EEPIYIVI-EYMSKGSLLDFL 103
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 17 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 77 NPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYV 108
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 22/83 (26%), Positives = 43/83 (51%), Gaps = 1/83 (1%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
++G G FG VYKG + + ++ + Q FKNEV +L + +H N++ +G+
Sbjct: 29 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 309 CLERKERILVYEFVPNASLDHFI 331
+ + +V ++ +SL H +
Sbjct: 89 S-TKPQLAIVTQWCEGSSLYHHL 110
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 2/81 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
KLGQG FG V+ G + +A+K L + E F E ++ +L+H LV+L
Sbjct: 15 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 311 ERKERILVYEFVPNASLDHFI 331
E I V E++ SL F+
Sbjct: 74 EEPIXI-VTEYMSKGSLLDFL 93
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
V + +LG G G V+ G + +AVK L + S + F E L+ +LQH+
Sbjct: 10 VPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 68
Query: 301 NLVRLLGFCLERKERI-LVYEFVPNASLDHFI 331
LVRL + + +E I ++ E++ N SL F+
Sbjct: 69 RLVRL--YAVVTQEPIYIITEYMENGSLVDFL 98
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 31/85 (36%), Positives = 46/85 (54%), Gaps = 8/85 (9%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSK--NSKQGEIEFK---NEVLLLARLQHRNLVRL 305
LG G FG V+KG+ + GE+I + K K G F+ + +L + L H ++VRL
Sbjct: 39 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 306 LGFCLERKERILVYEFVPNAS-LDH 329
LG C + LV +++P S LDH
Sbjct: 99 LGLCPGSSLQ-LVTQYLPLGSLLDH 122
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 20 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 80 NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYV 111
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 20 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 80 NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYV 111
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 39/82 (47%), Gaps = 1/82 (1%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
+LG G FG V G +AVK + + S E EF E + +L H LV+ G C
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 310 LERKERILVYEFVPNASLDHFI 331
+ +V E++ N L +++
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYL 94
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 76 NPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYV 107
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 23/85 (27%), Positives = 43/85 (50%), Gaps = 1/85 (1%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
++G G FG VYKG + + ++ + Q FKNEV +L + +H N++ +G+
Sbjct: 13 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 309 CLERKERILVYEFVPNASLDHFIFV 333
+ I V ++ +SL H + +
Sbjct: 73 STAPQLAI-VTQWCEGSSLYHHLHI 96
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 2/81 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
KLGQG FG V+ G + +A+K L + E F E ++ +L+H LV+L
Sbjct: 14 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 311 ERKERILVYEFVPNASLDHFI 331
E I V E++ SL F+
Sbjct: 73 EEPIYI-VTEYMSKGSLLDFL 92
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 2/81 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
KLGQG FG V+ G + +A+K L + E F E ++ +L+H LV+L
Sbjct: 16 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 311 ERKERILVYEFVPNASLDHFI 331
E I V E++ SL F+
Sbjct: 75 EEPIYI-VTEYMSKGSLLDFL 94
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 78 NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYV 109
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 17 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 77 NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYV 108
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 2/81 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
KLGQG FG V+ G + +A+K L + E F E ++ +L+H LV+L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 311 ERKERILVYEFVPNASLDHFI 331
E I V E++ SL F+
Sbjct: 250 EEPIYI-VTEYMSKGSLLDFL 269
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 76 NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYV 107
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 2/81 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
KLGQG FG V+ G + +A+K L + E F E ++ +L+H LV+L
Sbjct: 18 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 311 ERKERILVYEFVPNASLDHFI 331
E I V E++ SL F+
Sbjct: 77 EEPIYI-VTEYMSKGSLLDFL 96
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 78 NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYV 109
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 2/81 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
KLGQG FG V+ G + +A+K L + E F E ++ +L+H LV+L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 311 ERKERILVYEFVPNASLDHFI 331
E I V E++ SL F+
Sbjct: 250 EEPIYI-VTEYMSKGSLLDFL 269
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 28/84 (33%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG---EIE-FKNEVLLLARLQHRNLVRLLG 307
+G GGFG VY+ G+ +AVK + + IE + E L A L+H N++ L G
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 308 FCLERKERILVYEFVPNASLDHFI 331
CL+ LV EF L+ +
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVL 97
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 2/81 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
KLGQG FG V+ G + +A+K L + E F E ++ +L+H LV+L
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 311 ERKERILVYEFVPNASLDHFI 331
E I V E++ SL F+
Sbjct: 333 EEPIYI-VTEYMSKGSLLDFL 352
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 19 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 79 NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYV 110
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 2/81 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
KLGQG FG V+ G + +A+K L + E F E ++ +L+H LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFI 331
E I V E++ SL F+
Sbjct: 84 EEPIYI-VTEYMSKGSLLDFL 103
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 42/85 (49%), Gaps = 2/85 (2%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE--FKNEVLLLARLQHRNLVRLL 306
++G+G FG V+ G L T+ + + + +++ F E +L + H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 307 GFCLERKERILVYEFVPNASLDHFI 331
G C +++ +V E V F+
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL 203
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 42/85 (49%), Gaps = 2/85 (2%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE--FKNEVLLLARLQHRNLVRLL 306
++G+G FG V+ G L T+ + + + +++ F E +L + H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 307 GFCLERKERILVYEFVPNASLDHFI 331
G C +++ +V E V F+
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL 203
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 5/92 (5%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
N S +G G FG V G L S E ++A+K L +++ +F E ++ + H
Sbjct: 17 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
N++RL G + K ++V E + N SLD F+
Sbjct: 77 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL 108
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 78 NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYV 109
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 2/81 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
KLGQG FG V+ G + +A+K L + E F E ++ +L+H LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFI 331
E I V E++ SL F+
Sbjct: 84 EEPIYI-VTEYMSKGSLLDFL 103
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 31/85 (36%), Positives = 46/85 (54%), Gaps = 8/85 (9%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSK--NSKQGEIEFK---NEVLLLARLQHRNLVRL 305
LG G FG V+KG+ + GE+I + K K G F+ + +L + L H ++VRL
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 306 LGFCLERKERILVYEFVPNAS-LDH 329
LG C + LV +++P S LDH
Sbjct: 81 LGLCPGSSLQ-LVTQYLPLGSLLDH 104
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 76 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV 107
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 19 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 79 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV 110
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 76 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV 107
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 78 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV 109
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 5/92 (5%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
N S +G G FG V G L S E ++A+K L +++ +F E ++ + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
N++RL G + K ++V E + N SLD F+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL 137
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 78 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV 109
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 19 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 79 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV 110
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 70 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV 101
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 13 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 73 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV 104
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 7/92 (7%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A + +
Sbjct: 42 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
++ RLLG CL + L+ + +P L ++
Sbjct: 102 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV 132
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 26 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 86 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV 117
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 23 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 83 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV 114
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 5/92 (5%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
N S +G G FG V G L S E ++A+K L +++ +F E ++ + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
N++RL G + K ++V E + N SLD F+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL 137
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 19 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 79 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV 110
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 22 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 82 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV 113
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 23 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 83 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV 114
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 252 LGQGGFGAVYKGMLSNG---ETIAVKRLSK-NSKQGEIEFKNEVLLLARLQHR-NLVRLL 306
+G+G FG V K + A+KR+ + SK +F E+ +L +L H N++ LL
Sbjct: 23 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 307 GFCLERKERILVYEFVPNASLDHFI 331
G C R L E+ P+ +L F+
Sbjct: 83 GACEHRGYLYLAIEYAPHGNLLDFL 107
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 41.2 bits (95), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 252 LGQGGFGAVYKGMLSNG---ETIAVKRLSK-NSKQGEIEFKNEVLLLARLQHR-NLVRLL 306
+G+G FG V K + A+KR+ + SK +F E+ +L +L H N++ LL
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 307 GFCLERKERILVYEFVPNASLDHFI 331
G C R L E+ P+ +L F+
Sbjct: 93 GACEHRGYLYLAIEYAPHGNLLDFL 117
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 41.2 bits (95), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 76 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV 107
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 41.2 bits (95), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 2/81 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
KLGQG FG V+ G + +A+K L + E F E ++ +L+H LV+L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 311 ERKERILVYEFVPNASLDHFI 331
E I V E++ SL F+
Sbjct: 250 EEPIYI-VGEYMSKGSLLDFL 269
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 41.2 bits (95), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 2/81 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
KLGQG FG V+ G + +A+K L + E F E ++ +L+H LV+L
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 311 ERKERILVYEFVPNASLDHFI 331
E I V E++ SL F+
Sbjct: 251 EEPIYI-VTEYMSKGSLLDFL 270
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 41.2 bits (95), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 2/81 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
KLGQG FG V+ G + +A+K L + E F E ++ +L+H LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFI 331
E I V E++ SL F+
Sbjct: 84 EEPIYI-VCEYMSKGSLLDFL 103
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 41.2 bits (95), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 252 LGQGGFGAVYKGMLSNG---ETIAVKRLSK-NSKQGEIEFKNEVLLLARLQHR-NLVRLL 306
+G+G FG V K + A+KR+ + SK +F E+ +L +L H N++ LL
Sbjct: 30 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 307 GFCLERKERILVYEFVPNASLDHFI 331
G C R L E+ P+ +L F+
Sbjct: 90 GACEHRGYLYLAIEYAPHGNLLDFL 114
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 41.2 bits (95), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 2/81 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
KLGQG FG V+ G + +A+K L + E F E ++ +L+H LV+L
Sbjct: 22 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 311 ERKERILVYEFVPNASLDHFI 331
E I V E++ SL F+
Sbjct: 81 EEPIYI-VTEYMNKGSLLDFL 100
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 41.2 bits (95), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 22/83 (26%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
++G G FG VYKG + + ++ + Q FKNEV +L + +H N++ +G+
Sbjct: 29 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 309 CLERKERILVYEFVPNASLDHFI 331
+ +V ++ +SL H +
Sbjct: 89 STA-PQLAIVTQWCEGSSLYHHL 110
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 41.2 bits (95), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 2/81 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
KLGQG FG V+ G + +A+K L + E F E ++ +L+H LV+L
Sbjct: 22 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 311 ERKERILVYEFVPNASLDHFI 331
E I V E++ SL F+
Sbjct: 81 EEPIYI-VTEYMNKGSLLDFL 100
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 31/85 (36%), Positives = 46/85 (54%), Gaps = 8/85 (9%)
Query: 252 LGQGGFGAVYKGM-LSNGET----IAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
LG G FG VYKG+ + +GE +A+K L +N S + E +E ++A + + RL
Sbjct: 25 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 306 LGFCLERKERILVYEFVPNAS-LDH 329
LG CL + LV + +P LDH
Sbjct: 85 LGICLTSTVQ-LVTQLMPYGCLLDH 108
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 48/102 (47%), Gaps = 4/102 (3%)
Query: 235 DFETIRVATDN---FSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE-FKNE 290
++E +R D + +LG G FG VYK +A ++ + + E+E + E
Sbjct: 7 EYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVE 66
Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF 332
+ +LA H +V+LLG + ++ EF P ++D +
Sbjct: 67 IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIML 108
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 24/85 (28%), Positives = 44/85 (51%), Gaps = 5/85 (5%)
Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
+G G FG V +G L +A+K L +++ EF +E ++ + +H N++RL
Sbjct: 24 IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 307 GFCLERKERILVYEFVPNASLDHFI 331
G +++ EF+ N +LD F+
Sbjct: 84 GVVTNSMPVMILTEFMENGALDSFL 108
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 23/85 (27%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLLG 307
+LG G FG VYK +A ++ + + E+E + E+ +LA H +V+LLG
Sbjct: 16 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG 75
Query: 308 FCLERKERILVYEFVPNASLDHFIF 332
+ ++ EF P ++D +
Sbjct: 76 AYYHDGKLWIMIEFCPGGAVDAIML 100
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 24/85 (28%), Positives = 44/85 (51%), Gaps = 5/85 (5%)
Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
+G G FG V +G L +A+K L +++ EF +E ++ + +H N++RL
Sbjct: 22 IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 307 GFCLERKERILVYEFVPNASLDHFI 331
G +++ EF+ N +LD F+
Sbjct: 82 GVVTNSMPVMILTEFMENGALDSFL 106
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 40/81 (49%), Gaps = 2/81 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
KLGQG FG V+ G + +A+K L + E F E ++ +++H LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFI 331
E I V E++ SL F+
Sbjct: 84 EEPIYI-VTEYMSKGSLLDFL 103
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 4/104 (3%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEF 287
A L D R DNF K+G+G G V + S+G+ +AVK++ +Q
Sbjct: 139 ALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL 195
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
NEV+++ QH N+V + L E +V EF+ +L +
Sbjct: 196 FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV 239
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/77 (33%), Positives = 45/77 (58%), Gaps = 3/77 (3%)
Query: 238 TIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
++R A+D F + LGQG FG V K + + A+K++ +++++ +EV+LLA
Sbjct: 1 SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLAS 58
Query: 297 LQHRNLVRLLGFCLERK 313
L H+ +VR LER+
Sbjct: 59 LNHQYVVRYYAAWLERR 75
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 252 LGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
LG G FG V+K + G +A K + + + E KNE+ ++ +L H NL++L
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 311 ERKERILVYEFVPNASL 327
+ + +LV E+V L
Sbjct: 157 SKNDIVLVMEYVDGGEL 173
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 4/104 (3%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEF 287
A L D R DNF K+G+G G V + S+G+ +AVK++ +Q
Sbjct: 62 ALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL 118
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
NEV+++ QH N+V + L E +V EF+ +L +
Sbjct: 119 FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV 162
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 4/104 (3%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEF 287
A L D R DNF K+G+G G V + S+G+ +AVK++ +Q
Sbjct: 17 ALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL 73
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
NEV+++ QH N+V + L E +V EF+ +L +
Sbjct: 74 FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV 117
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/77 (33%), Positives = 45/77 (58%), Gaps = 3/77 (3%)
Query: 238 TIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
++R A+D F + LGQG FG V K + + A+K++ +++++ +EV+LLA
Sbjct: 1 SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLAS 58
Query: 297 LQHRNLVRLLGFCLERK 313
L H+ +VR LER+
Sbjct: 59 LNHQYVVRYYAAWLERR 75
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 4/104 (3%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEF 287
A L D R DNF K+G+G G V + S+G+ +AVK++ +Q
Sbjct: 19 ALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL 75
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
NEV+++ QH N+V + L E +V EF+ +L +
Sbjct: 76 FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV 119
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 24/79 (30%), Positives = 40/79 (50%), Gaps = 3/79 (3%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHRNL 302
+ K+G+G +G V+K E +A+KR+ + + E+ LL L+H+N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 303 VRLLGFCLERKERILVYEF 321
VRL K+ LV+EF
Sbjct: 64 VRLHDVLHSDKKLTLVFEF 82
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 4/93 (4%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
R DNF K+G+G G V + S+G+ +AVK++ +Q NEV+++ Q
Sbjct: 19 RSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ 75
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
H N+V + L E +V EF+ +L +
Sbjct: 76 HENVVEMYNSYLVGDELWVVMEFLEGGALTDIV 108
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 4/104 (3%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEF 287
A L D R DNF K+G+G G V + S+G+ +AVK++ +Q
Sbjct: 12 ALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL 68
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
NEV+++ QH N+V + L E +V EF+ +L +
Sbjct: 69 FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV 112
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 24/62 (38%), Positives = 37/62 (59%), Gaps = 3/62 (4%)
Query: 251 KLGQGGFGAVYKG-MLSNGETIAVKR-LSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLG 307
K+GQG FG V+K G+ +A+K+ L +N K+G I E+ +L L+H N+V L+
Sbjct: 25 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 308 FC 309
C
Sbjct: 85 IC 86
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 41/84 (48%), Gaps = 3/84 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL-GF 308
+LG G FG VYK +A ++ + E+E + E+ +LA H N+V+LL F
Sbjct: 44 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 309 CLERKERILVYEFVPNASLDHFIF 332
E IL+ EF ++D +
Sbjct: 104 YYENNLWILI-EFCAGGAVDAVML 126
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 15/82 (18%)
Query: 227 TIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEI 285
T+ K DF+ I + +G GGFG V+K +G+T +KR+ N+++ E
Sbjct: 4 TVDKRFGMDFKEIEL----------IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE- 52
Query: 286 EFKNEVLLLARLQHRNLVRLLG 307
EV LA+L H N+V G
Sbjct: 53 ---REVKALAKLDHVNIVHYNG 71
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 24/79 (30%), Positives = 40/79 (50%), Gaps = 3/79 (3%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHRNL 302
+ K+G+G +G V+K E +A+KR+ + + E+ LL L+H+N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 303 VRLLGFCLERKERILVYEF 321
VRL K+ LV+EF
Sbjct: 64 VRLHDVLHSDKKLTLVFEF 82
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 41/84 (48%), Gaps = 3/84 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL-GF 308
+LG G FG VYK +A ++ + E+E + E+ +LA H N+V+LL F
Sbjct: 44 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 309 CLERKERILVYEFVPNASLDHFIF 332
E IL+ EF ++D +
Sbjct: 104 YYENNLWILI-EFCAGGAVDAVML 126
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 41/84 (48%), Gaps = 3/84 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL-GF 308
+LG G FG VYK +A ++ + E+E + E+ +LA H N+V+LL F
Sbjct: 44 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 309 CLERKERILVYEFVPNASLDHFIF 332
E IL+ EF ++D +
Sbjct: 104 YYENNLWILI-EFCAGGAVDAVML 126
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 39/81 (48%), Gaps = 2/81 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
KLGQG FG V+ G + +A+K L + E F E ++ +L+H LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFI 331
E I V E++ L F+
Sbjct: 84 EEPIYI-VMEYMSKGCLLDFL 103
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 24/62 (38%), Positives = 37/62 (59%), Gaps = 3/62 (4%)
Query: 251 KLGQGGFGAVYKG-MLSNGETIAVKR-LSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLG 307
K+GQG FG V+K G+ +A+K+ L +N K+G I E+ +L L+H N+V L+
Sbjct: 25 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 308 FC 309
C
Sbjct: 85 IC 86
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 24/62 (38%), Positives = 37/62 (59%), Gaps = 3/62 (4%)
Query: 251 KLGQGGFGAVYKG-MLSNGETIAVKR-LSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLG 307
K+GQG FG V+K G+ +A+K+ L +N K+G I E+ +L L+H N+V L+
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 308 FC 309
C
Sbjct: 84 IC 85
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 24/62 (38%), Positives = 37/62 (59%), Gaps = 3/62 (4%)
Query: 251 KLGQGGFGAVYKG-MLSNGETIAVKR-LSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLG 307
K+GQG FG V+K G+ +A+K+ L +N K+G I E+ +L L+H N+V L+
Sbjct: 25 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 308 FC 309
C
Sbjct: 85 IC 86
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 39/81 (48%), Gaps = 2/81 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
KLGQG FG V+ G + +A+K L + E F E ++ +L+H LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFI 331
E I V E++ L F+
Sbjct: 84 EEPIYI-VTEYMSKGCLLDFL 103
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 22/87 (25%), Positives = 46/87 (52%), Gaps = 1/87 (1%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
++ K+GQG G VY M ++ G+ +A+++++ + + NE+L++ ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 305 LLGFCLERKERILVYEFVPNASLDHFI 331
L L E +V E++ SL +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV 108
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 22/87 (25%), Positives = 46/87 (52%), Gaps = 1/87 (1%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
++ K+GQG G VY M ++ G+ +A+++++ + + NE+L++ ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 305 LLGFCLERKERILVYEFVPNASLDHFI 331
L L E +V E++ SL +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV 108
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 22/87 (25%), Positives = 46/87 (52%), Gaps = 1/87 (1%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
++ K+GQG G VY M ++ G+ +A+++++ + + NE+L++ ++ N+V
Sbjct: 23 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 305 LLGFCLERKERILVYEFVPNASLDHFI 331
L L E +V E++ SL +
Sbjct: 83 YLDSYLVGDELWVVMEYLAGGSLTDVV 109
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 22/87 (25%), Positives = 46/87 (52%), Gaps = 1/87 (1%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
++ K+GQG G VY M ++ G+ +A+++++ + + NE+L++ ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 305 LLGFCLERKERILVYEFVPNASLDHFI 331
L L E +V E++ SL +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV 108
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 15/82 (18%)
Query: 227 TIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEI 285
T+ K DF+ I + +G GGFG V+K +G+T ++R+ N+++ E
Sbjct: 5 TVDKRFGMDFKEIEL----------IGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE- 53
Query: 286 EFKNEVLLLARLQHRNLVRLLG 307
EV LA+L H N+V G
Sbjct: 54 ---REVKALAKLDHVNIVHYNG 72
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 22/87 (25%), Positives = 46/87 (52%), Gaps = 1/87 (1%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
++ K+GQG G VY M ++ G+ +A+++++ + + NE+L++ ++ N+V
Sbjct: 23 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 305 LLGFCLERKERILVYEFVPNASLDHFI 331
L L E +V E++ SL +
Sbjct: 83 YLDSYLVGDELWVVMEYLAGGSLTDVV 109
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 31/112 (27%), Positives = 57/112 (50%), Gaps = 15/112 (13%)
Query: 219 LEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSK 278
L+D N + K L D +T +++ +G G FG V++ L + +A+K++ +
Sbjct: 18 LDDPN---KVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ 74
Query: 279 NSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCL---ERKERI---LVYEFVP 323
+ + FKN L + R+ +H N+V L F ++K+ + LV E+VP
Sbjct: 75 DKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F L G FG VYKG+ + GE + A+K L + S + E +E ++A +
Sbjct: 23 EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 83 NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYV 114
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F LG G FG VYKG+ + GE +A+ L + S + E +E ++A +
Sbjct: 50 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 110 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV 141
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F L G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 16 EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 76 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV 107
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 20/85 (23%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
+ ++G G FG VYKG + + ++ + + F+NEV +L + +H N++ +G+
Sbjct: 41 STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 309 CLERKERILVYEFVPNASLDHFIFV 333
+ + +V ++ +SL + V
Sbjct: 101 -MTKDNLAIVTQWCEGSSLYKHLHV 124
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
F L G FG VYKG+ + GE +A+K L + S + E +E ++A +
Sbjct: 23 EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ ++ RLLG CL + L+ + +P L ++
Sbjct: 83 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV 114
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/77 (33%), Positives = 44/77 (57%), Gaps = 3/77 (3%)
Query: 238 TIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
++R A+D F + LGQG FG V K + + A+K++ +++++ +EV LLA
Sbjct: 1 SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLAS 58
Query: 297 LQHRNLVRLLGFCLERK 313
L H+ +VR LER+
Sbjct: 59 LNHQYVVRYYAAWLERR 75
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/79 (32%), Positives = 45/79 (56%), Gaps = 8/79 (10%)
Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRL---SKNSKQGEIEFKNEVLLLARLQ-HRNLVRL 305
KLG+G +G V+K + GE +AVK++ +NS + F+ E+++L L H N+V L
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNL 74
Query: 306 LGFCLERKER--ILVYEFV 322
L +R LV++++
Sbjct: 75 LNVLRADNDRDVYLVFDYM 93
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 31/84 (36%), Positives = 42/84 (50%), Gaps = 8/84 (9%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
KLG G FG V +G +G+T+ AVK L + + +F EV + L HRNL+
Sbjct: 19 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 304 RLLGFCLERKERILVYEFVPNASL 327
RL G L + +V E P SL
Sbjct: 79 RLYGVVLTPPMK-MVTELAPLGSL 101
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 38.5 bits (88), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 31/84 (36%), Positives = 42/84 (50%), Gaps = 8/84 (9%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
KLG G FG V +G +G+T+ AVK L + + +F EV + L HRNL+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 304 RLLGFCLERKERILVYEFVPNASL 327
RL G L + +V E P SL
Sbjct: 75 RLYGVVLTPPMK-MVTELAPLGSL 97
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 38.5 bits (88), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 252 LGQGGFGAVYKGMLS-NGET---IAVKRL-SKNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
+G G FG V G L G+ +A+K L S +++ +F +E ++ + H N++ L
Sbjct: 41 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 307 GFCLERKERILVYEFVPNASLDHFI 331
G + +++ EF+ N SLD F+
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFL 125
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 38.5 bits (88), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 31/84 (36%), Positives = 42/84 (50%), Gaps = 8/84 (9%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
KLG G FG V +G +G+T+ AVK L + + +F EV + L HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 304 RLLGFCLERKERILVYEFVPNASL 327
RL G L + +V E P SL
Sbjct: 85 RLYGVVLTPPMK-MVTELAPLGSL 107
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 38.5 bits (88), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 31/84 (36%), Positives = 42/84 (50%), Gaps = 8/84 (9%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
KLG G FG V +G +G+T+ AVK L + + +F EV + L HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 304 RLLGFCLERKERILVYEFVPNASL 327
RL G L + +V E P SL
Sbjct: 85 RLYGVVLTPPMK-MVTELAPLGSL 107
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 38.5 bits (88), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 244 DNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNS--KQGEIE-FKNEVLLLARLQH 299
++F N LG+G F VY+ + G +A+K + K + K G ++ +NEV + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+++ L + + LV E N ++ ++
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYL 102
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 38.5 bits (88), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 31/84 (36%), Positives = 42/84 (50%), Gaps = 8/84 (9%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
KLG G FG V +G +G+T+ AVK L + + +F EV + L HRNL+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 304 RLLGFCLERKERILVYEFVPNASL 327
RL G L + +V E P SL
Sbjct: 75 RLYGVVLTPPMK-MVTELAPLGSL 97
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 38.5 bits (88), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 8/88 (9%)
Query: 252 LGQGGFGAV--YKGMLSN---GETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
LG+G FG V Y +N GE +AVK L + Q +K E+ +L L H ++++
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 306 LGFCLERKERI--LVYEFVPNASLDHFI 331
G C ++ E+ LV E+VP SL ++
Sbjct: 82 KGCCEDQGEKSLQLVMEYVPLGSLRDYL 109
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 38.5 bits (88), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 25/81 (30%), Positives = 39/81 (48%), Gaps = 2/81 (2%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
+LG G FG V+ G + +A+K L + E F E ++ +L+H LV+L
Sbjct: 16 RLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE-SFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 311 ERKERILVYEFVPNASLDHFI 331
E I V E++ SL F+
Sbjct: 75 EEPIYI-VTEYMNKGSLLDFL 94
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 8/88 (9%)
Query: 252 LGQGGFGAV--YKGMLSN---GETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
LG+G FG V Y +N GE +AVK L + Q +K E+ +L L H ++++
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 306 LGFCLERKERI--LVYEFVPNASLDHFI 331
G C ++ E+ LV E+VP SL ++
Sbjct: 82 KGCCEDQGEKSLQLVMEYVPLGSLRDYL 109
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 27/97 (27%), Positives = 49/97 (50%), Gaps = 4/97 (4%)
Query: 230 KSLQFDFETIRVATDNFSDANKLGQGGFGAV--YKGMLSNGETIAVKRLSKNSKQGEIEF 287
++L F + + ++ KLG+GGF V +G L +G A+KR+ + +Q E
Sbjct: 15 ENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEA 73
Query: 288 KNEVLLLARLQHRNLVRLLGFCL-ERKERILVYEFVP 323
+ E + H N++RL+ +CL ER + + +P
Sbjct: 74 QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 32/109 (29%), Positives = 53/109 (48%), Gaps = 4/109 (3%)
Query: 224 VEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG 283
+E T+A +F + +G+G FG V G G +AVK + KN
Sbjct: 173 MEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI-KNDATA 230
Query: 284 EIEFKNEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFI 331
+ F E ++ +L+H NLV+LLG +E K + +V E++ SL ++
Sbjct: 231 Q-AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL 278
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 252 LGQGGFGAVYKGMLS-NGET---IAVKRL-SKNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
+G G FG V G L G+ +A+K L S +++ +F +E ++ + H N++ L
Sbjct: 15 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 307 GFCLERKERILVYEFVPNASLDHFI 331
G + +++ EF+ N SLD F+
Sbjct: 75 GVVTKSTPVMIITEFMENGSLDSFL 99
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 38.1 bits (87), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 31/84 (36%), Positives = 42/84 (50%), Gaps = 8/84 (9%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
KLG G FG V +G +G+T+ AVK L + + +F EV + L HRNL+
Sbjct: 19 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 304 RLLGFCLERKERILVYEFVPNASL 327
RL G L + +V E P SL
Sbjct: 79 RLYGVVLTPPMK-MVTELAPLGSL 101
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 38.1 bits (87), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 31/84 (36%), Positives = 42/84 (50%), Gaps = 8/84 (9%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
KLG G FG V +G +G+T+ AVK L + + +F EV + L HRNL+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 304 RLLGFCLERKERILVYEFVPNASL 327
RL G L + +V E P SL
Sbjct: 75 RLYGVVLTPPMK-MVTELAPLGSL 97
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 23/87 (26%), Positives = 45/87 (51%), Gaps = 3/87 (3%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE--FKNEVLLLARLQHR 300
+ + K+G+G +G V+K G+ +A+K+ ++ I+ E+ +L +L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL 327
NLV LL ++ LV+E+ + L
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHTVL 89
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 24/85 (28%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
+G G FG V G L +A+K L +++ +F E ++ + H N++ L
Sbjct: 30 IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 307 GFCLERKERILVYEFVPNASLDHFI 331
G + K ++V E++ N SLD F+
Sbjct: 90 GVVTKSKPVMIVTEYMENGSLDTFL 114
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 40/83 (48%), Gaps = 4/83 (4%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
KLG G FG V+ + +AVK + S E F E ++ LQH LV+L
Sbjct: 21 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKL--HA 77
Query: 310 LERKERI-LVYEFVPNASLDHFI 331
+ KE I ++ EF+ SL F+
Sbjct: 78 VVTKEPIYIITEFMAKGSLLDFL 100
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 37.4 bits (85), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 40/83 (48%), Gaps = 4/83 (4%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
KLG G FG V+ + +AVK + S E F E ++ LQH LV+L
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKL--HA 244
Query: 310 LERKERI-LVYEFVPNASLDHFI 331
+ KE I ++ EF+ SL F+
Sbjct: 245 VVTKEPIYIITEFMAKGSLLDFL 267
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 37.4 bits (85), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 40/83 (48%), Gaps = 4/83 (4%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
KLG G FG V+ + +AVK + S E F E ++ LQH LV+L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKL--HA 250
Query: 310 LERKERI-LVYEFVPNASLDHFI 331
+ KE I ++ EF+ SL F+
Sbjct: 251 VVTKEPIYIITEFMAKGSLLDFL 273
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 37.4 bits (85), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 41/85 (48%), Gaps = 5/85 (5%)
Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
+G G FG V G L +A+K L +++ +F E ++ + H N+V L
Sbjct: 51 IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 307 GFCLERKERILVYEFVPNASLDHFI 331
G K ++V EF+ N +LD F+
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFL 135
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 37.4 bits (85), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 28/81 (34%), Positives = 45/81 (55%), Gaps = 4/81 (4%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
+G+G FG V G G +AVK + KN + F E ++ +L+H NLV+LLG +E
Sbjct: 29 IGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 312 RKERI-LVYEFVPNASLDHFI 331
K + +V E++ SL ++
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYL 106
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 37.4 bits (85), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 28/81 (34%), Positives = 45/81 (55%), Gaps = 4/81 (4%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
+G+G FG V G G +AVK + KN + F E ++ +L+H NLV+LLG +E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 312 RKERI-LVYEFVPNASLDHFI 331
K + +V E++ SL ++
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYL 91
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 37.4 bits (85), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 28/81 (34%), Positives = 45/81 (55%), Gaps = 4/81 (4%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
+G+G FG V G G +AVK + KN + F E ++ +L+H NLV+LLG +E
Sbjct: 20 IGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 312 RKERI-LVYEFVPNASLDHFI 331
K + +V E++ SL ++
Sbjct: 77 EKGGLYIVTEYMAKGSLVDYL 97
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 37.4 bits (85), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 26/91 (28%), Positives = 41/91 (45%), Gaps = 9/91 (9%)
Query: 243 TDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
+DN+ +LG+G F V + G+ + I K+LS Q + + E + +
Sbjct: 4 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 60
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASL 327
LQH N+VRL E LV++ V L
Sbjct: 61 LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 91
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 37.4 bits (85), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 5/76 (6%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
+G+G FG V K + +A+K++ S++ F E+ L+R+ H N+V+L G CL
Sbjct: 17 VGRGAFGVVCKAKW-RAKDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGACL- 72
Query: 312 RKERILVYEFVPNASL 327
LV E+ SL
Sbjct: 73 -NPVCLVMEYAEGGSL 87
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 37.4 bits (85), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 5/76 (6%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
+G+G FG V K + +A+K++ S++ F E+ L+R+ H N+V+L G CL
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGACL- 71
Query: 312 RKERILVYEFVPNASL 327
LV E+ SL
Sbjct: 72 -NPVCLVMEYAEGGSL 86
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 37.0 bits (84), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 26/91 (28%), Positives = 41/91 (45%), Gaps = 9/91 (9%)
Query: 243 TDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
+DN+ +LG+G F V + G+ + I K+LS Q + + E + +
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 61
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASL 327
LQH N+VRL E LV++ V L
Sbjct: 62 LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 92
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 37.0 bits (84), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 40/85 (47%), Gaps = 1/85 (1%)
Query: 244 DNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL 302
D++ +LG G FG V++ + G A K + + + + E+ ++ L+H L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 303 VRLLGFCLERKERILVYEFVPNASL 327
V L + E +++YEF+ L
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGEL 241
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 37.0 bits (84), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 26/91 (28%), Positives = 41/91 (45%), Gaps = 9/91 (9%)
Query: 243 TDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
+DN+ +LG+G F V + G+ + I K+LS Q + + E + +
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 61
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASL 327
LQH N+VRL E LV++ V L
Sbjct: 62 LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 92
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 37.0 bits (84), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 40/85 (47%), Gaps = 1/85 (1%)
Query: 244 DNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL 302
D++ +LG G FG V++ + G A K + + + + E+ ++ L+H L
Sbjct: 51 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 303 VRLLGFCLERKERILVYEFVPNASL 327
V L + E +++YEF+ L
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGEL 135
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 37.0 bits (84), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 23/64 (35%), Positives = 35/64 (54%), Gaps = 5/64 (7%)
Query: 252 LGQGGFGAVYKG----MLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL 306
+G+G FG VY G N A+K LS+ ++ ++E F E LL+ L H N++ L+
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 307 GFCL 310
G L
Sbjct: 89 GIML 92
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 36.6 bits (83), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 252 LGQGGFGAVYKGML-----SNGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
LG+G FG V GE +AVK L + Q ++ E+ +L L H ++V+
Sbjct: 17 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 306 LGFCLERKERI--LVYEFVPNASLDHFI 331
G C ++ E+ LV E+VP SL ++
Sbjct: 77 KGCCEDQGEKSVQLVMEYVPLGSLRDYL 104
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 36.6 bits (83), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 252 LGQGGFGAVYKGML-----SNGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
LG+G FG V GE +AVK L + Q ++ E+ +L L H ++V+
Sbjct: 16 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 306 LGFCLERKERI--LVYEFVPNASLDHFI 331
G C ++ E+ LV E+VP SL ++
Sbjct: 76 KGCCEDQGEKSVQLVMEYVPLGSLRDYL 103
>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase
Length = 353
Score = 36.6 bits (83), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 44/90 (48%), Gaps = 17/90 (18%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHR 300
+ +G G +G+V + +GE +A+K+LS+ Q EI K E+LLL +QH
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHE 83
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHF 330
N++ LL F P +SL +F
Sbjct: 84 NVIGLLDV------------FTPASSLRNF 101
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 36.6 bits (83), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 26/91 (28%), Positives = 41/91 (45%), Gaps = 9/91 (9%)
Query: 243 TDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
+DN+ +LG+G F V + G+ + I K+LS Q + + E + +
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 84
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASL 327
LQH N+VRL E LV++ V L
Sbjct: 85 LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 115
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 36.6 bits (83), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 40/85 (47%), Gaps = 1/85 (1%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL 302
D + +LG G FG V++ + + G K ++ + KNE+ ++ +L H L
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110
Query: 303 VRLLGFCLERKERILVYEFVPNASL 327
+ L ++ E +L+ EF+ L
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGEL 135
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 36.6 bits (83), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 31/112 (27%), Positives = 50/112 (44%), Gaps = 10/112 (8%)
Query: 229 AKSL-QFDFETIRVATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIE 286
A+SL + D +R F +G G +G VYKG + G+ A+K + + E E
Sbjct: 8 ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-E 66
Query: 287 FKNEVLLLARL-QHRNLVRLLGFCLER------KERILVYEFVPNASLDHFI 331
K E+ +L + HRN+ G +++ + LV EF S+ I
Sbjct: 67 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI 118
>pdb|4EXU|A Chain A, Mapk13, Inactive Form
pdb|4EYJ|A Chain A, Mapk13 Complex With Inhibitor
pdb|4EYM|A Chain A, Mapk13 Complex With Inhibitor
Length = 371
Score = 36.6 bits (83), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 44/90 (48%), Gaps = 17/90 (18%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHR 300
+ +G G +G+V + +GE +A+K+LS+ Q EI K E+LLL +QH
Sbjct: 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHE 101
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHF 330
N++ LL F P +SL +F
Sbjct: 102 NVIGLLDV------------FTPASSLRNF 119
>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
pdb|1TKI|B Chain B, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
Length = 321
Score = 36.2 bits (82), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 21/87 (24%), Positives = 46/87 (52%), Gaps = 2/87 (2%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
+ + A LG+G FG V++ + ++ + + + K ++ K E+ +L +HRN++
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 304 RLLGFCLERKERILVYEFVPNASLDHF 330
L +E ++++EF+ + LD F
Sbjct: 65 HLHESFESMEELVMIFEFI--SGLDIF 89
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 36.2 bits (82), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 23/85 (27%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
+G G FG V G L +A+K L + + +F +E ++ + H N++ L
Sbjct: 37 IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 307 GFCLERKERILVYEFVPNASLDHFI 331
G + K +++ E++ N SLD F+
Sbjct: 97 GVVTKCKPVMIITEYMENGSLDAFL 121
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 36.2 bits (82), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 23/85 (27%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
+G G FG V G L +A+K L + + +F +E ++ + H N++ L
Sbjct: 16 IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 307 GFCLERKERILVYEFVPNASLDHFI 331
G + K +++ E++ N SLD F+
Sbjct: 76 GVVTKCKPVMIITEYMENGSLDAFL 100
>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From
Crystallographic Fragment Screen
Length = 301
Score = 36.2 bits (82), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 32 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 92 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 121
>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution
pdb|1XR1|A Chain A, Crystal Structure Of Hpim-1 Kinase In Complex With Amp-Pnp
At 2.1 A Resolution
Length = 300
Score = 36.2 bits (82), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 31 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 91 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 120
>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From
Crystallographic Fragment Screen
pdb|2XIZ|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-3 From
Crystallographic Fragment Screen
pdb|2XJ1|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inibitor
pdb|2XJ2|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inhibitor
Length = 301
Score = 36.2 bits (82), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 32 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 92 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 121
>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa
Length = 300
Score = 36.2 bits (82), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 31 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 91 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 120
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 36.2 bits (82), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 17/59 (28%), Positives = 31/59 (52%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
+G+G FG VY G I + + ++++ FK EV+ + +H N+V +G C+
Sbjct: 41 IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 36.2 bits (82), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 23/85 (27%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
+G G FG V G L +A+K L + + +F +E ++ + H N++ L
Sbjct: 22 IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 307 GFCLERKERILVYEFVPNASLDHFI 331
G + K +++ E++ N SLD F+
Sbjct: 82 GVVTKCKPVMIITEYMENGSLDAFL 106
>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From
Crystallographic Fragment Screen
Length = 301
Score = 36.2 bits (82), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 32 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 92 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 121
>pdb|3A2E|A Chain A, Crystal Structure Of Ginkbilobin-2, The Novel Antifungal
Protein From Ginkgo Biloba Seeds
pdb|3A2E|B Chain B, Crystal Structure Of Ginkbilobin-2, The Novel Antifungal
Protein From Ginkgo Biloba Seeds
pdb|3A2E|C Chain C, Crystal Structure Of Ginkbilobin-2, The Novel Antifungal
Protein From Ginkgo Biloba Seeds
pdb|3A2E|D Chain D, Crystal Structure Of Ginkbilobin-2, The Novel Antifungal
Protein From Ginkgo Biloba Seeds
Length = 108
Score = 36.2 bits (82), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 18/66 (27%), Positives = 26/66 (39%)
Query: 97 YATGKEAVSDIVTMYALVQCTPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFR 156
Y T + T Y C +S++DC CL + + C+ G RV C +
Sbjct: 43 YKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFSICNNAIGARVQLVDCFIQ 102
Query: 157 YETNKF 162
YE F
Sbjct: 103 YEQRSF 108
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 36.2 bits (82), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 22/98 (22%), Positives = 47/98 (47%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D + LG+G FG V K T+AVK L ++ + ++ + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ E+ +L ++
Sbjct: 95 KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of
P27kip1 Carboxy-Terminal Peptide
Length = 320
Score = 35.8 bits (81), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 111 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 140
>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Pyrrolo[2,3- A]carbazole Ligand
pdb|3QF9|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Furan- Thiazolidinedione Ligand
pdb|4GW8|A Chain A, Human Proto-Oncogene Serine Threonine Kinase (Pim1) In
Complex With A Consensus Peptide And Leucettine L41
Length = 313
Score = 35.8 bits (81), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 45 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 134
>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain
Length = 313
Score = 35.8 bits (81), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 44 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 133
>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Naphtho-Difuran Ligand
Length = 313
Score = 35.8 bits (81), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 45 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 134
>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand I
pdb|3CY2|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand Ii
Length = 314
Score = 35.8 bits (81), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 45 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 134
>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With
Ly333531
Length = 312
Score = 35.8 bits (81), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 44 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 133
>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its
Consensus Peptide Pimtide
pdb|2BZJ|A Chain A, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru3
pdb|2BZK|B Chain B, Crystal Structure Of The Human Pim1 In Complex With Amppnp
And Pimtide
pdb|2C3I|B Chain B, Crystal Structure Of Human Pim1 In Complex With
Imidazopyridazin I
pdb|2BZH|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2OI4|X Chain X, Crystal Structure Of Human Pim1 In Complex With
Fluorinated Ruthenium Pyridocarbazole
pdb|3BWF|A Chain A, Crystal Structure Of The Human Pim1 In Complex With An
Osmium Compound
Length = 313
Score = 35.8 bits (81), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 44 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 133
>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And
The Jnk Inhibitor V
Length = 314
Score = 35.8 bits (81), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 45 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 134
>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target
Of Aberrant Somatic Hypermutations In Diffuse Large Cell
Lymphoma
pdb|1YXT|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amppnp
pdb|1YXU|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|B Chain B, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|C Chain C, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|D Chain D, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXV|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
3,4-Dihydroxy-1- Methylquinolin-2(1h)-One
pdb|1YXX|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
(3e)-3-[(4- Hydroxyphenyl)imino]-1h-Indol-2(3h)-One
pdb|2O3P|A Chain A, Crystal Structure Of Pim1 With Quercetin
pdb|2O63|A Chain A, Crystal Structure Of Pim1 With Myricetin
pdb|2O64|A Chain A, Crystal Structure Of Pim1 With Quercetagetin
pdb|2O65|A Chain A, Crystal Structure Of Pim1 With Pentahydroxyflavone
Length = 293
Score = 35.8 bits (81), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 16 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 76 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 105
>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261
pdb|2BZI|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru2
Length = 313
Score = 35.8 bits (81), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 44 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 133
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 35.8 bits (81), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 244 DNFSDAN-KLGQGGFGAVYKG---MLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQ 298
DN A+ +LG G FG+V +G M +A+K L + +++ + E E ++ +L
Sbjct: 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 394
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +VRL+G C + + +LV E L F+
Sbjct: 395 NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFL 426
>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small
Molecule Inhibitor
pdb|3UMX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indol-3-Yl)methylene]-7-(Azepan-1-Ylmethyl)-6-
Hydroxybenzofuran- 3(2h)-One
pdb|4ENX|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
Inhibitor (2e,5z)-2-
(2-Chlorophenylimino)-5-(4-Hydroxy-3-
Nitrobenzylidene)thiazolidin-4- One
pdb|4ENY|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
(2e,5z)-2-(2-
Chlorophenylimino)-5-(4-Hydroxy-3-
Methoxybenzylidene)thiazolidin-4- One
pdb|3UMW|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indazol-3-Yl)methylene]-6-Methoxy-7-(Piperazin-1-
Ylmethyl)benzofuran- 3(2h)-One
Length = 298
Score = 35.8 bits (81), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 17 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 77 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 106
>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JY0|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JYA|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
Length = 294
Score = 35.8 bits (81), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 17 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 77 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 106
>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With
4-(4-
Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One
pdb|3T9I|A Chain A, Pim1 Complexed With A Novel 3,6-Disubstituted Indole At
2.6 Ang Resolution
Length = 328
Score = 35.8 bits (81), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 59 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 119 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 148
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 35.8 bits (81), Expect = 0.037, Method: Compositional matrix adjust.
Identities = 23/85 (27%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 252 LGQGGFGAVYKGML----SNGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
+G G G V G L +A+K L +++ +F +E ++ + H N++RL
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 307 GFCLERKERILVYEFVPNASLDHFI 331
G + ++V E++ N SLD F+
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL 141
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 35.8 bits (81), Expect = 0.038, Method: Compositional matrix adjust.
Identities = 21/81 (25%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 252 LGQGGFG-AVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
LG+G FG A+ GE + +K L + ++ + F EV ++ L+H N+++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 311 ERKERILVYEFVPNASLDHFI 331
+ K + E++ +L I
Sbjct: 78 KDKRLNFITEYIKGGTLRGII 98
>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
pdb|4ALW|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 35.8 bits (81), Expect = 0.038, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 59 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 119 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 148
>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R01|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R02|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R04|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3VBQ|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBT|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBV|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBW|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBX|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBY|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VC4|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
Length = 299
Score = 35.8 bits (81), Expect = 0.038, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 17 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 77 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 106
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 35.8 bits (81), Expect = 0.038, Method: Compositional matrix adjust.
Identities = 23/85 (27%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 252 LGQGGFGAVYKGML----SNGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
+G G G V G L +A+K L +++ +F +E ++ + H N++RL
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 307 GFCLERKERILVYEFVPNASLDHFI 331
G + ++V E++ N SLD F+
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL 141
>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major
pdb|3E3P|B Chain B, Glycogen Synthase Kinase From Leishmania Major
Length = 360
Score = 35.8 bits (81), Expect = 0.039, Method: Compositional matrix adjust.
Identities = 31/101 (30%), Positives = 46/101 (45%), Gaps = 17/101 (16%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLL-- 293
E R D F GQG FG V G S G ++A+K++ ++ + F+N L
Sbjct: 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQIM 70
Query: 294 --LARLQHRNLVRLLGFCLERKERI-------LVYEFVPNA 325
LA L H N+V+L + ER +V E+VP+
Sbjct: 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT 111
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 35.8 bits (81), Expect = 0.039, Method: Compositional matrix adjust.
Identities = 22/98 (22%), Positives = 47/98 (47%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D + LG+G FG V K T+AVK L ++ + ++ + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ E+ +L ++
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 35.8 bits (81), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 22/98 (22%), Positives = 47/98 (47%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D + LG+G FG V K T+AVK L ++ + ++ + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ E+ +L ++
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With
Inhibitor
pdb|3BGP|A Chain A, Human Pim-1 Complexed With A Benzoisoxazole Inhibitor Vx1
pdb|3BGQ|A Chain A, Human Pim-1 Kinase In Complex With An Triazolo Pyridazine
Inhibitor Vx2
pdb|3BGZ|A Chain A, Human Pim-1 Kinase In Complex With Diphenyl Indole
Inhibitor Vx3
Length = 333
Score = 35.4 bits (80), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 64 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 124 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 153
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 35.4 bits (80), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 22/98 (22%), Positives = 47/98 (47%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D + LG+G FG V K T+AVK L ++ + ++ + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ E+ +L ++
Sbjct: 95 KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 35.4 bits (80), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 22/98 (22%), Positives = 47/98 (47%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D + LG+G FG V K T+AVK L ++ + ++ + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ E+ +L ++
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor
Length = 276
Score = 35.4 bits (80), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 15 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 75 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 104
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 35.4 bits (80), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 22/98 (22%), Positives = 47/98 (47%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D + LG+G FG V K T+AVK L ++ + ++ + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ E+ +L ++
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|B Chain B, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|C Chain C, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|D Chain D, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
Length = 273
Score = 35.4 bits (80), Expect = 0.047, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 72 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 101
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 35.4 bits (80), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 37/76 (48%), Gaps = 3/76 (3%)
Query: 255 GGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL-GFCLER 312
G FG VYK +A ++ + E+E + E+ +LA H N+V+LL F E
Sbjct: 21 GDFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 80
Query: 313 KERILVYEFVPNASLD 328
IL+ EF ++D
Sbjct: 81 NLWILI-EFCAGGAVD 95
>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546
Length = 308
Score = 35.4 bits (80), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 39 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 99 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 128
>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors
Length = 273
Score = 35.4 bits (80), Expect = 0.049, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 72 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 101
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 35.4 bits (80), Expect = 0.051, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 39/81 (48%), Gaps = 2/81 (2%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGE-IEFKNEVLLLARLQHRN 301
+ + +KLG+G + VYKG +A+K + ++G EV LL L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 302 LVRLLGFCLERKERILVYEFV 322
+V L K LV+E++
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYL 82
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 35.4 bits (80), Expect = 0.051, Method: Compositional matrix adjust.
Identities = 22/98 (22%), Positives = 47/98 (47%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D + LG+G FG V K T+AVK L ++ + ++ + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ E+ +L ++
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine
pdb|1YI3|A Chain A, Crystal Structure Of Pim-1 Bound To Ly294002
pdb|1YI4|A Chain A, Structure Of Pim-1 Bound To Adenosine
Length = 273
Score = 35.0 bits (79), Expect = 0.055, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+RLL + ER + ++ P D F F+
Sbjct: 72 IRLLDW-FERPDSFVLILERPEPVQDLFDFI 101
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 35.0 bits (79), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 244 DNFSDAN-KLGQGGFGAVYKG---MLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQ 298
DN A+ +LG G FG+V +G M +A+K L + +++ + E E ++ +L
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 68
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +VRL+G C + + +LV E L F+
Sbjct: 69 NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFL 100
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 34.7 bits (78), Expect = 0.070, Method: Compositional matrix adjust.
Identities = 23/62 (37%), Positives = 33/62 (53%), Gaps = 11/62 (17%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAV-------KRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
++G+G F VYKG L T+ V ++L+K+ +Q FK E L LQH N+V
Sbjct: 33 EIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIV 88
Query: 304 RL 305
R
Sbjct: 89 RF 90
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 34.7 bits (78), Expect = 0.080, Method: Compositional matrix adjust.
Identities = 22/87 (25%), Positives = 43/87 (49%), Gaps = 3/87 (3%)
Query: 246 FSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
F KLG+G +G+VYK + G+ +A+K++ S EI E+ ++ + ++V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEI--IKEISIMQQCDSPHVVK 88
Query: 305 LLGFCLERKERILVYEFVPNASLDHFI 331
G + + +V E+ S+ I
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDII 115
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 34.7 bits (78), Expect = 0.080, Method: Compositional matrix adjust.
Identities = 22/98 (22%), Positives = 47/98 (47%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D + LG+G FG V K T+AVK L ++ + ++ + +E+ ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ E+ +L ++
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 178
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 34.3 bits (77), Expect = 0.092, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 41/91 (45%), Gaps = 4/91 (4%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS---KNSKQGEIEFKNEVLLLARLQHR 300
NF K+G+G F VY+ L +G +A+K++ + + E+ LL +L H
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFI 331
N+++ +E E +V E L I
Sbjct: 93 NVIKYYASFIEDNELNIVLELADAGDLSRMI 123
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 34.3 bits (77), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 22/98 (22%), Positives = 47/98 (47%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D + LG+G FG V K T+AVK L ++ + ++ + +E+ ++
Sbjct: 22 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ E+ +L ++
Sbjct: 82 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 119
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 34.3 bits (77), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 22/98 (22%), Positives = 47/98 (47%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D + LG+G FG V K T+AVK L ++ + ++ + +E+ ++
Sbjct: 27 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ E+ +L ++
Sbjct: 87 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 124
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 34.3 bits (77), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 22/98 (22%), Positives = 47/98 (47%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D + LG+G FG V K T+AVK L ++ + ++ + +E+ ++
Sbjct: 24 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ E+ +L ++
Sbjct: 84 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 121
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 34.3 bits (77), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 252 LGQGGFGAV--YKGMLSN---GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRL 305
LG+G FG V Y +N GE +AVK L ++ Q +K E+ +L L H ++++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 306 LGFCLE--RKERILVYEFVPNASLDHFI 331
G C + LV E+VP SL ++
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYL 126
>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain With
Amppnp
pdb|3DGK|A Chain A, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain
Length = 295
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 9/96 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
D + +LG G F V K G+ + I KR +K+S++G + + EV +L
Sbjct: 11 DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+QH N++ L + + IL+ E V L F+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant
Length = 334
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 9/96 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
D + +LG G F V K G+ + I KR +K+S++G + + EV +L
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+QH N++ L + + IL+ E V L F+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mn.
pdb|1JKL|A Chain A, 1.6a X-Ray Structure Of Binary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue
pdb|1JKS|A Chain A, 1.5a X-Ray Structure Of Apo Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|A Chain A, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|B Chain B, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKK|A Chain A, 2.4a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mg.
pdb|3F5G|A Chain A, Crystal Structure Of Death Associated Protein Kinase In
Complex With Adp And Mg2+
pdb|3EH9|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Adp
pdb|3EHA|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Amppnp
Length = 294
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 42/95 (44%), Gaps = 7/95 (7%)
Query: 244 DNFSDANKLGQGGFGAVYK-----GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLAR 296
D + +LG G F V K L KR +K+S++G + + EV +L
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+QH N++ L + + IL+ E V L F+
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFL 104
>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With
Bound Inhibitor Fragment
Length = 293
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 42/95 (44%), Gaps = 7/95 (7%)
Query: 244 DNFSDANKLGQGGFGAVYK-----GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLAR 296
D + +LG G F V K L KR +K+S++G + + EV +L
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+QH N++ L + + IL+ E V L F+
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFL 104
>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex
Length = 334
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 9/96 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
D + +LG G F V K G+ + I KR +K+S++G + + EV +L
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+QH N++ L + + IL+ E V L F+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase
In Complex With Amppnp And Mg2+
Length = 295
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 42/95 (44%), Gaps = 7/95 (7%)
Query: 244 DNFSDANKLGQGGFGAVYK-----GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLAR 296
D + +LG G F V K L KR +K+S++G + + EV +L
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+QH N++ L + + IL+ E V L F+
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation
Length = 293
Score = 33.9 bits (76), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 25/78 (32%), Positives = 42/78 (53%), Gaps = 9/78 (11%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQH--RNL 302
LG GGFG+VY G+ +S+ +A+K + K+ S GE+ EV+LL ++ +
Sbjct: 16 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 303 VRLLGFCLERKERILVYE 320
+RLL + +L+ E
Sbjct: 76 IRLLDWFERPDSFVLILE 93
>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In
Complex With A Ruthenium Octasporine Ligand (Osv)
pdb|2Y4P|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|3ZXT|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
Length = 285
Score = 33.9 bits (76), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 9/96 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
D + +LG G F V K G+ + I KR +K+S++G + + EV +L
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+QH N++ L + + IL+ E V L F+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312
pdb|2XZS|B Chain B, Death Associated Protein Kinase 1 Residues 1-312
Length = 312
Score = 33.9 bits (76), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 9/96 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
D + +LG G F V K G+ + I KR +K+S++G + + EV +L
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+QH N++ L + + IL+ E V L F+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277
Length = 277
Score = 33.5 bits (75), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 42/95 (44%), Gaps = 7/95 (7%)
Query: 244 DNFSDANKLGQGGFGAVYK-----GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLAR 296
D + +LG G F V K L KR +K+S++G + + EV +L
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+QH N++ L + + IL+ E V L F+
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVX|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVY|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
Length = 278
Score = 33.5 bits (75), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 9/96 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
D + +LG G F V K G+ + I KR +K+S++G + + EV +L
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+QH N++ L + + IL+ E V L F+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302
Length = 302
Score = 33.5 bits (75), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 9/96 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
D + +LG G F V K G+ + I KR +K+S++G + + EV +L
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+QH N++ L + + IL+ E V L F+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 33.5 bits (75), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 8/96 (8%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
+N LG G FG V + G +AVK L + E E +E+ +++
Sbjct: 31 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
L QH N+V LLG C +++ E+ L +F+
Sbjct: 91 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL 126
>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp
pdb|3GU5|A Chain A, Crystal Structure Of Dapkq23v-Amppnp-Mg2+
pdb|3GU6|A Chain A, Crystal Structure Of Dapkq23v-Adp
pdb|3GU7|A Chain A, Crystal Structure Of Dapkq23v-Adp-Mg2+
Length = 295
Score = 33.5 bits (75), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 9/96 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
D + +LG G F V K G+ + I KR +K+S++G + + EV +L
Sbjct: 11 DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+QH N++ L + + IL+ E V L F+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 33.5 bits (75), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 28/103 (27%), Positives = 44/103 (42%), Gaps = 8/103 (7%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIE-FKN 289
E +N LG G FG V + G +AVK L + E E +
Sbjct: 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 290 EVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
E+ +++ L QH N+V LLG C +++ E+ L +F+
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL 141
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 33.5 bits (75), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 8/96 (8%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
+N LG G FG V + G +AVK L + E E +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
L QH N+V LLG C +++ E+ L +F+
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL 141
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 33.5 bits (75), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 8/96 (8%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
+N LG G FG V + G +AVK L + E E +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
L QH N+V LLG C +++ E+ L +F+
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL 141
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 33.5 bits (75), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 26/117 (22%), Positives = 48/117 (41%), Gaps = 12/117 (10%)
Query: 228 IAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI-- 285
I+ L+ E + + F+ LG+G FG+V + L + VK K K I
Sbjct: 7 ISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS 66
Query: 286 ----EFKNEVLLLARLQHRNLVRLLGFCLERKER------ILVYEFVPNASLDHFIF 332
EF E + H ++ +L+G L + + +++ F+ + L F+
Sbjct: 67 SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL 123
>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304
Length = 326
Score = 33.5 bits (75), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 42/95 (44%), Gaps = 7/95 (7%)
Query: 244 DNFSDANKLGQGGFGAVYK-----GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLAR 296
D + +LG G F V K L KR +K+S++G + + EV +L
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+QH N++ L + + IL+ E V L F+
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 33.1 bits (74), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 21/98 (21%), Positives = 46/98 (46%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D + LG+G FG V K T+AVK L ++ + ++ + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ + +L ++
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYL 132
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 33.1 bits (74), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 8/96 (8%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
+N LG G FG V + G +AVK L + E E +E+ +++
Sbjct: 38 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
L QH N+V LLG C +++ E+ L +F+
Sbjct: 98 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 33.1 bits (74), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 27/86 (31%), Positives = 41/86 (47%), Gaps = 8/86 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSNGETI--AVKRLSKNSKQGEIE-FKNEVLLLAR 296
+N LG G FG V G+ G +I AVK L + + E E +E+ ++ +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 297 L-QHRNLVRLLGFCLERKERILVYEF 321
L H N+V LLG C L++E+
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEY 130
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 33.1 bits (74), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 25/75 (33%), Positives = 37/75 (49%), Gaps = 3/75 (4%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLS-KNSKQGEIEFKNEVLLLARL 297
R TD F LG+GGFG V++ + A+KR+ N + + EV LA+L
Sbjct: 2 RYLTD-FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 60
Query: 298 QHRNLVRLLGFCLER 312
+H +VR LE+
Sbjct: 61 EHPGIVRYFNAWLEK 75
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 33.1 bits (74), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 8/96 (8%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
+N LG G FG V + G +AVK L + E E +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
L QH N+V LLG C +++ E+ L +F+
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL 141
>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine
pdb|3GUB|A Chain A, Crystal Structure Of Dapkl93g Complexed With N6-(2-
Phenylethyl)adenosine
Length = 295
Score = 33.1 bits (74), Expect = 0.26, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 42/95 (44%), Gaps = 7/95 (7%)
Query: 244 DNFSDANKLGQGGFGAVYK-----GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLAR 296
D + +LG G F V K L KR +K+S++G + + EV +L
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+QH N++ L + + IL+ E V L F+
Sbjct: 71 IQHPNVITLHEVYENKTDVILIGELVAGGELFDFL 105
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 32.7 bits (73), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSN--GETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
+ S LG G FG V + G++ + T+AVK L ++ E E +E+ +L+
Sbjct: 41 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
L H N+V LLG C +++ E+ L +F+
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 136
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 32.7 bits (73), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSN--GETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
+ S LG G FG V + G++ + T+AVK L ++ E E +E+ +L+
Sbjct: 46 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
L H N+V LLG C +++ E+ L +F+
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 141
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 32.7 bits (73), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 38/82 (46%), Gaps = 1/82 (1%)
Query: 251 KLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
K+G+G G V G+ +AVK++ +Q NEV+++ H N+V +
Sbjct: 52 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 310 LERKERILVYEFVPNASLDHFI 331
L E +V EF+ +L +
Sbjct: 112 LVGDELWVVMEFLEGGALTDIV 133
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 32.7 bits (73), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSN--GETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
+ S LG G FG V + G++ + T+AVK L ++ E E +E+ +L+
Sbjct: 39 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
L H N+V LLG C +++ E+ L +F+
Sbjct: 99 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 134
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 32.7 bits (73), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSN--GETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
+ S LG G FG V + G++ + T+AVK L ++ E E +E+ +L+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
L H N+V LLG C +++ E+ L +F+
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 32.7 bits (73), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 3/88 (3%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS--KNSKQGEIEFKNEVLLLARLQH 299
TD + +LG+G F V + M + G+ A K ++ K S + + + E + L+H
Sbjct: 3 TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASL 327
N+VRL E LV++ V L
Sbjct: 63 PNIVRLHDSISEEGFHYLVFDLVTGGEL 90
>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839
pdb|2IO6|A Chain A, Wee1 Kinase Complexed With Inhibitor Pd330961
Length = 287
Score = 32.7 bits (73), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 6/90 (6%)
Query: 243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN---EVLLLARL- 297
T F + K+G G FG+V+K + +G A+KR SK G ++ +N EV A L
Sbjct: 8 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 66
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASL 327
QH ++VR E ++ E+ SL
Sbjct: 67 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSL 96
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 32.7 bits (73), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSN--GETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
+ S LG G FG V + G++ + T+AVK L ++ E E +E+ +L+
Sbjct: 46 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
L H N+V LLG C +++ E+ L +F+
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 141
>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396
pdb|3BIZ|A Chain A, Wee1 Kinase Complex With Inhibitor Pd331618
pdb|3CQE|A Chain A, Wee1 Kinase Complex With Inhibitor Pd074291
pdb|3CR0|A Chain A, Wee1 Kinase Complex With Inhibitor Pd259_809
Length = 287
Score = 32.7 bits (73), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 6/90 (6%)
Query: 243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN---EVLLLARL- 297
T F + K+G G FG+V+K + +G A+KR SK G ++ +N EV A L
Sbjct: 8 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 66
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASL 327
QH ++VR E ++ E+ SL
Sbjct: 67 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSL 96
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 32.7 bits (73), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 21/98 (21%), Positives = 46/98 (46%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D + LG+G FG V K T+AVK L ++ + ++ + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ + +L ++
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYL 132
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 32.7 bits (73), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 3/88 (3%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS--KNSKQGEIEFKNEVLLLARLQH 299
TD + +LG+G F V + M + G+ A K ++ K S + + + E + L+H
Sbjct: 3 TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASL 327
N+VRL E LV++ V L
Sbjct: 63 PNIVRLHDSISEEGFHYLVFDLVTGGEL 90
>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed
With Inhibitor Pd0407824
Length = 289
Score = 32.7 bits (73), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 6/90 (6%)
Query: 243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN---EVLLLARL- 297
T F + K+G G FG+V+K + +G A+KR SK G ++ +N EV A L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 68
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASL 327
QH ++VR E ++ E+ SL
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSL 98
>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770
Length = 285
Score = 32.3 bits (72), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 6/90 (6%)
Query: 243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN---EVLLLARL- 297
T F + K+G G FG+V+K + +G A+KR SK G ++ +N EV A L
Sbjct: 6 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 64
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASL 327
QH ++VR E ++ E+ SL
Sbjct: 65 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSL 94
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 32.3 bits (72), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 28/91 (30%), Positives = 39/91 (42%), Gaps = 14/91 (15%)
Query: 251 KLGQGGFGAVYKGMLSNGET---IAVKRLS-----------KNSKQGEIEFKNEVLLLAR 296
KLG G +G V NG + I V + S KN ++ E NE+ LL
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASL 327
L H N+++L ++K LV EF L
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL 133
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 32.3 bits (72), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 24/74 (32%), Positives = 36/74 (48%), Gaps = 3/74 (4%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLS-KNSKQGEIEFKNEVLLLARL 297
R TD F +G+GGFG V++ + A+KR+ N + + EV LA+L
Sbjct: 3 RYLTD-FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
Query: 298 QHRNLVRLLGFCLE 311
+H +VR LE
Sbjct: 62 EHPGIVRYFNAWLE 75
>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2IWI|B Chain B, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
Length = 312
Score = 32.3 bits (72), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 26/93 (27%), Positives = 46/93 (49%), Gaps = 12/93 (12%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN------EVLLLARL----QHR 300
LG+GGFG V+ G L++ +A+K + +N G + EV LL ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFV 333
++RLL + E +E ++ P + D F ++
Sbjct: 99 GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYI 130
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 32.3 bits (72), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 27/109 (24%), Positives = 48/109 (44%), Gaps = 9/109 (8%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGEI 285
L +D A + LG+G FG V + T+AVK L + + E
Sbjct: 15 LPYDASKWEFARERLKLGKSLGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEY 74
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILV-YEFVPNASLDHFI 331
+ E+ +L + H N+V LLG C ++ ++V E+ +L +++
Sbjct: 75 KALMTELKILTHIGHHLNVVNLLGACTKQGGPLMVIVEYCKYGNLSNYL 123
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 32.0 bits (71), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 19/83 (22%), Positives = 46/83 (55%), Gaps = 2/83 (2%)
Query: 246 FSDANKLGQGGFGAVYKGMLSNG-ETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHRNLV 303
F+ +++G+G FG VYKG+ ++ E +A+K + + ++ + + E+ +L++ +
Sbjct: 21 FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 304 RLLGFCLERKERILVYEFVPNAS 326
R G L+ + ++ E++ S
Sbjct: 81 RYFGSYLKSTKLWIIMEYLGGGS 103
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 32.0 bits (71), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 4/61 (6%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNS---KQGEIEFKNEVLLL 294
I + ++FS +G+GGFG VY ++ G+ A+K L K KQGE NE ++L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 295 A 295
+
Sbjct: 244 S 244
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 32.0 bits (71), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 4/61 (6%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNS---KQGEIEFKNEVLLL 294
I + ++FS +G+GGFG VY ++ G+ A+K L K KQGE NE ++L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 295 A 295
+
Sbjct: 244 S 244
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 32.0 bits (71), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 4/61 (6%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNS---KQGEIEFKNEVLLL 294
I + ++FS +G+GGFG VY ++ G+ A+K L K KQGE NE ++L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 295 A 295
+
Sbjct: 244 S 244
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 32.0 bits (71), Expect = 0.50, Method: Compositional matrix adjust.
Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 4/61 (6%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNS---KQGEIEFKNEVLLL 294
I + ++FS +G+GGFG VY ++ G+ A+K L K KQGE NE ++L
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 295 A 295
+
Sbjct: 243 S 243
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 32.0 bits (71), Expect = 0.52, Method: Compositional matrix adjust.
Identities = 31/95 (32%), Positives = 45/95 (47%), Gaps = 9/95 (9%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIE---FKNEVLL 293
R+ DNF LG+G FG V + G+ AVK L K+ + ++E + +L
Sbjct: 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 294 LARLQHRNLVRLLGFCLERKERI-LVYEFVPNASL 327
LAR H L +L C + +R+ V EFV L
Sbjct: 79 LAR-NHPFLTQLFC-CFQTPDRLFFVMEFVNGGDL 111
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 32.0 bits (71), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 39/82 (47%), Gaps = 1/82 (1%)
Query: 251 KLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
K+G+G G V +G +AVK + +Q NEV+++ QH N+V +
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 310 LERKERILVYEFVPNASLDHFI 331
L +E ++ EF+ +L +
Sbjct: 112 LVGEELWVLMEFLQGGALTDIV 133
>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
pdb|3ZUU|B Chain B, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
Length = 362
Score = 31.6 bits (70), Expect = 0.66, Method: Compositional matrix adjust.
Identities = 24/87 (27%), Positives = 38/87 (43%), Gaps = 4/87 (4%)
Query: 243 TDNFSDANKLGQGGFGA--VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
+D + +G G FG + + SN E +AVK + + K E K E++ L+H
Sbjct: 18 SDRYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIDE-NVKREIINHRSLRHP 75
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL 327
N+VR L +V E+ L
Sbjct: 76 NIVRFKEVILTPTHLAIVMEYASGGEL 102
>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase
pdb|3ZUT|B Chain B, The Structure Of Ost1 (D160a) Kinase
Length = 362
Score = 31.6 bits (70), Expect = 0.67, Method: Compositional matrix adjust.
Identities = 24/87 (27%), Positives = 38/87 (43%), Gaps = 4/87 (4%)
Query: 243 TDNFSDANKLGQGGFGA--VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
+D + +G G FG + + SN E +AVK + + K E K E++ L+H
Sbjct: 18 SDRYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIDE-NVKREIINHRSLRHP 75
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL 327
N+VR L +V E+ L
Sbjct: 76 NIVRFKEVILTPTHLAIVMEYASGGEL 102
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 31.6 bits (70), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 19/62 (30%), Positives = 33/62 (53%), Gaps = 3/62 (4%)
Query: 246 FSDANKLGQGGFGAVYKGMLSNGETI--AVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
++ N +G+G +G V K + G I A K++ K + FK E+ ++ L H N++
Sbjct: 11 YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 304 RL 305
RL
Sbjct: 70 RL 71
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 31.6 bits (70), Expect = 0.71, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 37/77 (48%), Gaps = 6/77 (7%)
Query: 252 LGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-----EVLLLARLQHRNLVRL 305
LG+G F VYK N + +A+K++ + + N E+ LL L H N++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 306 LGFCLERKERILVYEFV 322
L + LV++F+
Sbjct: 78 LDAFGHKSNISLVFDFM 94
>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1
Length = 361
Score = 31.6 bits (70), Expect = 0.75, Method: Compositional matrix adjust.
Identities = 24/87 (27%), Positives = 38/87 (43%), Gaps = 4/87 (4%)
Query: 243 TDNFSDANKLGQGGFGA--VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
+D + +G G FG + + SN E +AVK + + K E K E++ L+H
Sbjct: 17 SDRYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIDE-NVKREIINHRSLRHP 74
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL 327
N+VR L +V E+ L
Sbjct: 75 NIVRFKEVILTPTHLAIVMEYASGGEL 101
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 31.2 bits (69), Expect = 0.80, Method: Compositional matrix adjust.
Identities = 19/62 (30%), Positives = 33/62 (53%), Gaps = 3/62 (4%)
Query: 246 FSDANKLGQGGFGAVYKGMLSNGETI--AVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
++ N +G+G +G V K + G I A K++ K + FK E+ ++ L H N++
Sbjct: 28 YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 304 RL 305
RL
Sbjct: 87 RL 88
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 31.2 bits (69), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 21/98 (21%), Positives = 46/98 (46%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D LG+G FG V K + +AVK L ++ + ++ + +E+ ++
Sbjct: 28 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ E+ +L ++
Sbjct: 88 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 125
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 31.2 bits (69), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 22/78 (28%), Positives = 37/78 (47%), Gaps = 3/78 (3%)
Query: 252 LGQGGFGAVY--KGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
LG G F V+ K L+ G+ A+K + K+ + +NE+ +L +++H N+V L
Sbjct: 17 LGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 310 LERKERILVYEFVPNASL 327
LV + V L
Sbjct: 76 ESTTHYYLVMQLVSGGEL 93
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 31.2 bits (69), Expect = 0.84, Method: Compositional matrix adjust.
Identities = 21/98 (21%), Positives = 46/98 (46%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D LG+G FG V K + +AVK L ++ + ++ + +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ E+ +L ++
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 110
>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
pdb|2WTK|F Chain F, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
Length = 305
Score = 31.2 bits (69), Expect = 0.89, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 42/79 (53%), Gaps = 11/79 (13%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSK-------QGEIEFKNEVLLLARLQHRNLVR 304
LG+G +G V + + + ET+ + + K GE K E+ LL RL+H+N+++
Sbjct: 13 LGEGSYGKVKEVL--DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 305 LLGFCL--ERKERILVYEF 321
L+ E+++ +V E+
Sbjct: 71 LVDVLYNEEKQKMYMVMEY 89
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 31.2 bits (69), Expect = 0.95, Method: Compositional matrix adjust.
Identities = 21/98 (21%), Positives = 46/98 (46%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D LG+G FG V K + +AVK L ++ + ++ + +E+ ++
Sbjct: 20 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ E+ +L ++
Sbjct: 80 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 117
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 31.2 bits (69), Expect = 0.95, Method: Compositional matrix adjust.
Identities = 21/98 (21%), Positives = 46/98 (46%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D LG+G FG V K + +AVK L ++ + ++ + +E+ ++
Sbjct: 17 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ E+ +L ++
Sbjct: 77 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 114
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 31.2 bits (69), Expect = 0.95, Method: Compositional matrix adjust.
Identities = 21/98 (21%), Positives = 46/98 (46%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D LG+G FG V K + +AVK L ++ + ++ + +E+ ++
Sbjct: 21 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ E+ +L ++
Sbjct: 81 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 118
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 30.8 bits (68), Expect = 1.00, Method: Compositional matrix adjust.
Identities = 21/98 (21%), Positives = 46/98 (46%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D LG+G FG V K + +AVK L ++ + ++ + +E+ ++
Sbjct: 28 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ E+ +L ++
Sbjct: 88 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 125
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 30.8 bits (68), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 21/98 (21%), Positives = 46/98 (46%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D LG+G FG V K + +AVK L ++ + ++ + +E+ ++
Sbjct: 28 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ E+ +L ++
Sbjct: 88 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 125
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 30.8 bits (68), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 21/98 (21%), Positives = 46/98 (46%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D LG+G FG V K + +AVK L ++ + ++ + +E+ ++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ E+ +L ++
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 166
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 30.8 bits (68), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 21/98 (21%), Positives = 46/98 (46%), Gaps = 10/98 (10%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
D LG+G FG V K + +AVK L ++ + ++ + +E+ ++
Sbjct: 28 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+ +H+N++ LLG C + ++ E+ +L ++
Sbjct: 88 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 125
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 30.8 bits (68), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 36/78 (46%), Gaps = 2/78 (2%)
Query: 252 LGQGGFG-AVYKGMLSNGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFC 309
LG G F V + G+ AVK + K + +G E +NE+ +L +++H N+V L
Sbjct: 30 LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIY 89
Query: 310 LERKERILVYEFVPNASL 327
LV + V L
Sbjct: 90 ESPNHLYLVMQLVSGGEL 107
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 30.8 bits (68), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 25/98 (25%), Positives = 44/98 (44%), Gaps = 5/98 (5%)
Query: 245 NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHR 300
N+ +G+G F V + G+ +AVK + K NS + F+ EV ++ L H
Sbjct: 8 NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 66
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFVGIWLQ 338
N+V+L K LV E+ + ++ W++
Sbjct: 67 NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMK 104
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 30.8 bits (68), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 37/91 (40%), Gaps = 9/91 (9%)
Query: 243 TDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
TD + +G+G F V + G + I K+LS Q + + E +
Sbjct: 3 TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQ---KLEREARICRL 59
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASL 327
L+H N+VRL E LV++ V L
Sbjct: 60 LKHSNIVRLHDSISEEGFHYLVFDLVTGGEL 90
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 30.4 bits (67), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 39/91 (42%), Gaps = 9/91 (9%)
Query: 243 TDNFSDANKLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
TD++ +LG+G F V + + + I K+LS Q + + E +
Sbjct: 30 TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQ---KLEREARICRL 86
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASL 327
L+H N+VRL E LV++ V L
Sbjct: 87 LKHPNIVRLHDSISEEGFHYLVFDLVTGGEL 117
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 30.4 bits (67), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 23/97 (23%), Positives = 48/97 (49%), Gaps = 6/97 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAVY--KGMLSNGETIAVKRL---SKNSKQGEIEFKNEVLLL 294
++ + + +KLG GG VY + + N + +A+K + + ++ F+ EV
Sbjct: 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIK-VAIKAIFIPPREKEETLKRFEREVHNS 65
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
++L H+N+V ++ E LV E++ +L +I
Sbjct: 66 SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI 102
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 30.4 bits (67), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 46/99 (46%), Gaps = 9/99 (9%)
Query: 241 VATDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVL 292
+ D++ +LG G F V K G + I +RLS +S++G E + EV
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS-SSRRGVSREEIEREVN 60
Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
+L ++H N++ L + + +L+ E V L F+
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL 99
>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|B Chain B, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|C Chain C, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|D Chain D, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|E Chain E, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|F Chain F, Crystal Structure Of Human Pas Kinase Bound To Adp
Length = 335
Score = 30.4 bits (67), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 25/102 (24%), Positives = 48/102 (47%), Gaps = 14/102 (13%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK----------NSKQGEIEFKNEV 291
+ +S + LG G FG V+ + + + VK + K + K G++ E+
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL--EI 80
Query: 292 LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFV 333
+L+R++H N++++L + LV E + LD F F+
Sbjct: 81 AILSRVEHANIIKVLDIFENQGFFQLVME-KHGSGLDLFAFI 121
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 30.0 bits (66), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 45/96 (46%), Gaps = 9/96 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
D++ +LG G F V K G + I +RLS +S++G E + EV +L
Sbjct: 12 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS-SSRRGVSREEIEREVNILR 70
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
++H N++ L + + +L+ E V L F+
Sbjct: 71 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL 106
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 30.0 bits (66), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 18/66 (27%), Positives = 35/66 (53%), Gaps = 3/66 (4%)
Query: 242 ATDNFSDANKLGQGGFG-AVYKGMLSNGETIAVKRL--SKNSKQGEIEFKNEVLLLARLQ 298
+ + + K+G+G FG A+ +G +K + S+ S + E + EV +LA ++
Sbjct: 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK 81
Query: 299 HRNLVR 304
H N+V+
Sbjct: 82 HPNIVQ 87
>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6
pdb|3UDB|B Chain B, Crystal Structure Of Snrk2.6
pdb|3UDB|C Chain C, Crystal Structure Of Snrk2.6
pdb|3UDB|D Chain D, Crystal Structure Of Snrk2.6
pdb|3UDB|E Chain E, Crystal Structure Of Snrk2.6
pdb|3UDB|F Chain F, Crystal Structure Of Snrk2.6
Length = 317
Score = 30.0 bits (66), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 23/87 (26%), Positives = 38/87 (43%), Gaps = 4/87 (4%)
Query: 243 TDNFSDANKLGQGGFGA--VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
+D + +G G FG + + +N E +AVK + + K E K E++ L+H
Sbjct: 18 SDRYELVKDIGAGNFGVARLMRDKQAN-ELVAVKYIERGEKIDE-NVKREIINHRSLRHP 75
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL 327
N+VR L +V E+ L
Sbjct: 76 NIVRFKEVILTPTHLAIVMEYASGGEL 102
>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6
pdb|3UC4|B Chain B, The Crystal Structure Of Snf1-Related Kinase 2.6
Length = 362
Score = 30.0 bits (66), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 23/87 (26%), Positives = 37/87 (42%), Gaps = 4/87 (4%)
Query: 243 TDNFSDANKLGQGGFGA--VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
+D + +G G FG + + SN E +AVK + + K K E++ L+H
Sbjct: 18 SDRYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIAA-NVKREIINHRSLRHP 75
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL 327
N+VR L +V E+ L
Sbjct: 76 NIVRFKEVILTPTHLAIVMEYASGGEL 102
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 29.6 bits (65), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 23/91 (25%), Positives = 37/91 (40%), Gaps = 9/91 (9%)
Query: 243 TDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
T+ + +LG+G F V + G I K+LS Q + + E +
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ---KLEREARICRL 66
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASL 327
L+H N+VRL E L+++ V L
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL 97
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 29.3 bits (64), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 25/98 (25%), Positives = 45/98 (45%), Gaps = 7/98 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSK----NSKQG--EIEFKNEVLL 293
+ D++ +LG G F V K G+ A K + K +S++G E + EV +
Sbjct: 23 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNI 82
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
L ++H N++ L + + +L+ E V L F+
Sbjct: 83 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL 120
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 28.9 bits (63), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 16/61 (26%), Positives = 32/61 (52%), Gaps = 1/61 (1%)
Query: 246 FSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
+ D LG GG G V+ + ++ + +A+K++ Q E+ ++ RL H N+V+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 305 L 305
+
Sbjct: 73 V 73
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 28.9 bits (63), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 35/84 (41%), Gaps = 9/84 (10%)
Query: 250 NKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
+LG+G F V + G + I K+LS Q + + E + L+H N+V
Sbjct: 28 EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKHPNIV 84
Query: 304 RLLGFCLERKERILVYEFVPNASL 327
RL E L+++ V L
Sbjct: 85 RLHDSISEEGHHYLIFDLVTGGEL 108
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 28.9 bits (63), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 24/86 (27%), Positives = 39/86 (45%), Gaps = 3/86 (3%)
Query: 243 TDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
+D F ++LG+G VY+ + A+K L K + + + E+ +L RL H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV--RTEIGVLLRLSHPN 109
Query: 302 LVRLLGFCLERKERILVYEFVPNASL 327
+++L E LV E V L
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL 135
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 27.7 bits (60), Expect = 8.6, Method: Compositional matrix adjust.
Identities = 23/71 (32%), Positives = 37/71 (52%), Gaps = 5/71 (7%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQG-EIEFKNEVLLL 294
E IR D F D LG G F V + +A+K ++K + +G E +NE+ +L
Sbjct: 14 EDIRDIYD-FRDV--LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 295 ARLQHRNLVRL 305
+++H N+V L
Sbjct: 71 HKIKHPNIVAL 81
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 27.7 bits (60), Expect = 8.9, Method: Compositional matrix adjust.
Identities = 23/71 (32%), Positives = 37/71 (52%), Gaps = 5/71 (7%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQG-EIEFKNEVLLL 294
E IR D F D LG G F V + +A+K ++K + +G E +NE+ +L
Sbjct: 14 EDIRDIYD-FRDV--LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 295 ARLQHRNLVRL 305
+++H N+V L
Sbjct: 71 HKIKHPNIVAL 81
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 27.7 bits (60), Expect = 9.6, Method: Compositional matrix adjust.
Identities = 23/71 (32%), Positives = 37/71 (52%), Gaps = 5/71 (7%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQG-EIEFKNEVLLL 294
E IR D F D LG G F V + +A+K ++K + +G E +NE+ +L
Sbjct: 14 EDIRDIYD-FRDV--LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 295 ARLQHRNLVRL 305
+++H N+V L
Sbjct: 71 HKIKHPNIVAL 81
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.320 0.137 0.412
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 9,634,921
Number of Sequences: 62578
Number of extensions: 372040
Number of successful extensions: 1902
Number of sequences better than 100.0: 569
Number of HSP's better than 100.0 without gapping: 195
Number of HSP's successfully gapped in prelim test: 374
Number of HSP's that attempted gapping in prelim test: 1441
Number of HSP's gapped (non-prelim): 575
length of query: 340
length of database: 14,973,337
effective HSP length: 99
effective length of query: 241
effective length of database: 8,778,115
effective search space: 2115525715
effective search space used: 2115525715
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 52 (24.6 bits)